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CHAPTER –I 
INTRODUCTION 
 
BACKGROUND OF THE STUDY 
 Cell is the structural and the functional unit of all the organisms on the earth and 
Cell Science is a scientific discipline that studies the structure and the physiological 
characters of these cells. Human beings are multi-cellular organisms with an estimated 
100,000,000,000,000 cells.  
Cord blood stem cell research has been extensively explored worldwide to 
enhance human health in medical setting. Stem cells have tremendous promise to 
helping us to understand and treat a range of various diseases, injuries and other health-
related conditions. Their potential is evident in the use of cord blood stem cells to treat 
diseases of the blood, A cord blood stem cell therapy has saved the lives of thousands of 
children with leukemia; and can be seen in the use of stem cells for tissue grafts to treat 
diseases or injury to the bone, skin and surface of the eye. Important clinical trials 
involving stem cells are underway for many other conditions and researchers continue to 
explore new avenues using stem cells in medicine. 
Cord blood stem cell research has the potential to teach us more about how birth 
defects occur and how these can be prevented or possibly reversed. An understanding of 
the regulation and chemical triggers of stem cell proliferation and differentiation are key 
to addressing birth defects. 
 Cord blood stem cells are undifferentiated biological cells that can differentiate 
into specialized cells and can be divided and to produce more cord blood stem cells. Stem 
cells sources are A. Adult/somatic stem cell 1. Bone marrow (drilling into femur or iliac 
crest) 2. Adipose tissue – lipids cells extr1acted by liposuction. 3. Blood – Blood from 
the donor passed through a machine that extracts stem cells. B. Umbilical cord blood C. 
Blastocyst 
  Cord blood stem cell researchers are making great advances in understanding 
normal development, figuring out what goes wrong in disease and developing and testing 
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potential treatments of patients.They still have so much to learn, however, about how 
stem cells work in the body and their capacity for healing , safe and effective treatments 
for most of the diseases, various conditions and different types of  injuries are in the 
future.  
 Cord blood stem cells are the foundation for every organ and tissue in our body. 
There are many different types of stem cells that comes from different places in the body 
are formed at different times in our lives. These include 1. Embryonic stem cells.  
2.Tissue-specific stem cells 3.Mesenchymal stem cells–Bone Marrow 4. Induced 
pluripotent stem cells – Skin Cells to embroyonic 5.Haematopoietic stem cells found in 
umbilical cord. 
Embryonic stem cells are obtained from the inner cell mass of the blastocyst, a 
mainly hollow ball of cells, in the human, forms between three to five days after an egg 
cell is fertilized by a sperm. A human blastocyst is about the size of the dot above this 
―I.‖ Embryonic stem cells are pluripotent, meaning they can give rise to every cell type in 
the fully formed body, but not the placenta and umbilical cord.  
Tissue-specific stem cells (also referred to as somatic or adult stem cells) are 
more specialized than the embryonic stem cells. Typically, these stem cells can generate 
different cell types for the specific tissue or organ in which they live. For example, blood-
forming (or hematopoietic) stem cells in the bone marrow can give rise to red blood cells, 
white blood cells and platelets.Tissue-specific stem cells are difficult to find in the human 
body, and they don‘t seem to self-renew in culture as easily as embryonic stem cells do.  
Mesenchymal Stem Cells are multipotent stem cells normally found in the bone 
marrow and are derived from mesenchyme. They differentiate into adipocytes, 
chondrocytes, osteoblasts, myocytes and tendon. Mesenchymal Stem Cells can also be 
extracted from blood, fallopian tube, fetal liver and lungs. 
Induced pluripotent stem cells  are cells that have been engineered in the lab by 
converting tissue-specific cells, such as skin cells, into cells that behave like embryonic 
stem cells. Induced pluripotent stem cells are critical tools to help scientists learn more 
about normal development and disease onset and progression, and they are also useful for 
developing and testing new drugs and therapies. 
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The umbilical cord blood contains haematopoietic stem cells - similar to those 
found in the bone marrow - and which can be used to generate red blood cells and cells of 
the immune system. Cord blood stem cells are currently used to treat a range of blood 
disorders and immune system conditions such as leukaemia, anaemia and autoimmune 
diseases. These stem cells are used largely in the treatment of children but have also 
started being used in adults following chemotherapy treatment. 
The future experts believe that umbilical cord blood is an important source 
of haematopoietic stem cells and expect that its full potential for treatment of blood 
disorders is yet to be revealed. Other types of stem cells such as induced pluripotent 
stem cells may prove to be better suited to treating non-blood-related diseases, but 
this question can only be answered by further research. 
NEED FOR THE STUDY 
 This study aimed to assess the level of stem cell knowledge, attitude toward stem 
cell application in medicine.Now-a-days prenatal mothers may have inadequate 
knowledge and attitude regarding Cord blood stem cell therapy.Umbilical cord 
blood supplies are not sufficient to meet the high transfusion needs. This study was 
designed to determine opinion about preservation of umbilical cord blood, identify the 
reasons for the lack of motivation to donate umbilical cord blood and allow experts to 
establish better recruitment campaigns to enrich the donor pool. 
Cerebral palsy, a condition where the brain is unable to control the muscles of the 
body, impacts as many as 10,000 newborns each, according to the Center for Disease 
Control (CDC).  An experimental procedure at Duke University in North Carolina is 
being used with great success to treat this condition.  Children with cerebral palsy are 
being infused with their own cord blood stem cells to heal and repair damaged brain 
tissue.   
Clearly, stem cell use is exciting and holds great promise for treating and curing 
many diseases in the future. Their importance ranges from an understanding of the 
principles behind human development to the cell based therapies addressing those aspects 
that go away during development and lead to treating a disease. 
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For those who are already suffering from a disease that stem cells can treat, such 
as certain cancer types, stem cells may currently have more personal importance and 
relevance. For others, it is likely that at some point in their life, they or a loved one will 
be affected by a disease that stem cells can treat, so it's good to keep abreast of stem cell 
research. Improve the health and well being of the person those love by preservation of 
umbilical cord blood stem cells. 
As Cord blood stem cells have an ability to grow and differentiate, they are being 
considered as the treatment option to replace the diseased cells, tissue repairs so as to 
improve the efficiency and working of a failing organ and organ system e.g. failing heart 
to function due to damage to the cardiac tissues and muscles. Thus stem cells offer the 
possibility of a renewable source for replacement of the affected cells and tissues to treat 
variety of diseases, trauma and injuries. Stem-cell banks help to preserve the embryonic 
stem cells that can be used to treat diseases in adult-life and this practice of preservation 
is the boon for the mankind. 
Genetic disorder rate in india 64.4 % (per 1000 live births),Rao and Ghose (2005) 
report that 1 out of 20 children admitted to hospital has a genetic disorder that ultimately 
account for about 1 out of 10 childhood deaths. In India ultimately urban area are affected 
with congenital malformation and genetic disorder are the third most common cause of 
mortality in newborns.  
Haemophilia A (clotting factor VIII deficiency; MIM: 306700) is the most 
common form of the disorder, occurring at about 1 in 5,000 to 10,000 male births. 
Haemophilia B (factor IX deficiency; MIM: 306900) occurs at about 1 in about 20,000-
34,000 male births, with no significant racial difference. Female carriers may also bleed 
abnormally, because some have low levels of the relevant clotting factor. The birth rate 
haemophilia in India is 32 per 1,000 live births. Thalassemia is a blood related 
disorder that is mostly transmitted in autosomal recessive mode. There are an estimated 
60-80 million people in the world who carry the beta thalassemia trait. People who carry 
thalassemia in India alone number approximately 30 million.  In India, beta thalassemia 
is very common in the north eastern region with a frequency of 7-64%. High frequency of 
beta thalassemia trait is also reported in Gujarat, Punjab, Tamil Nadu and West Bengal. 
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In Namakkal district (3 male and 0 female) among men head and neck cancers (10 cases) 
and genitor urinary cancer (9 cases are prevalent) 
Umbilical cord blood collected at birth is a rich source of stem cells that can be 
used in research and in the clinic to treat various diseases of the blood and immune 
system. With the consent of the parents, blood can be collected from the umbilical cord 
of a newborn baby shortly after birth. This does not hurt the baby or the mother in any 
way, and it is blood that would otherwise be discarded as biological waste along with the 
placenta (another rich source of stem cells) after the birth.  
The Cord blood stem cell  therapy is needed to treat children with cancerous 
blood disorders such as leukemia, or genetic blood diseases like fanconi anaemia.The 
cord blood is transplanted into the patient , where the (HSCs) Haematopoietic stem cells 
can make new, healthy blood cells to replace those damaged by the patient‘s disease or 
by a medical treatment such as chemotherapy for cancer. 
Researcher have a own interest to do research on knowledge and attitude 
regarding stem cell therapy among antenatal mothers. 
STATEMENT OF THE PROBLEM 
 A study to assess the effectiveness of Structured Teaching Programme on 
knowledge and attitude regarding cord blood stem cell therapy among antenatal mothers 
in selected private hospitals at Namakkal dist. 
OBJECTIVES 
1. To assess the pre test knowledge and attitude regarding cord blood stem cell  
    therapy among antenatal mothers   
2. To assess the effectiveness of structured teaching programme on cord blood  
    stem cell therapy among antenatal mothers  
3. To correlate knowledge and attitude regarding cord blood stem cell therapy  
    among antenatal mothers  
4. To find the association between post test knowledge and attitude regarding  
    stem cell therapy among antenatal mothers with their selected demographic  
    variables such as Age ,Religion, Gravida, Education, Previous source on cord  
    blood stem cell therapy. 
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HYPOTHESIS  
 H1- There will be significant difference between pre and post test knowledge 
and attitude score regarding cord blood stem cell therapy among antenatal 
mothers. 
 
 H2- There will be significant association between post test knowledge and   
attitude score with selected demographic variables such as (Age, Religion, 
Gravida, Education, Previous source on cord blood stem cell therapy) 
 
 H3-There will be relationship between post test knowledge and attitude with 
selected demographic variables such as (Age, Religion, Gravida, Education, 
Previous source on cord blood stem cell therapy). 
OPERATONAL DEFINITIONS   
Assess 
It refers to value the level of knowledge and attitude regarding cord blood stem 
cell therapy among antenatal mothers  
Effectiveness 
It refers to significant gain in knowledge and attitude as determined by significant 
difference between pre and post test knowledge and attitude score after structured 
teaching programme. 
Structured teaching programme  
It refers to the systematically arranged information regarding Introduction, 
Normal cell structure, Normal cell division, Definition, History, 
Types,Properties,Diseases treated by umbilical cord blood,Procedure,Nurses 
responsibilities of cord blood stem cells. 
Knowledge 
It refers to the information acquired from structure teaching programme regarding 
importance of stem cell therapy, In this study knowledge is classified in to three levels, 
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Score   level of knowledge  
 
≤50%    Inadequate Knowledge 
 
51 – 75%                                      Moderately Adequate Knowledge 
 
>75%    Adequate Knowledge 
 
 Attitude 
        An attitude is a expression of Strongly Agree, Agree, Neither Agree nor Disagree, 
Disagree, Strongly Disagree, response of a antenatal mothers towards stem cell therapy   
Classification of attitude by score 
Score   Attitude Level  
≤50%    Favorable attitude 
51 – 75%                                      Moderately Favorable attitude 
>75%    Unfavorable attitude 
 
 This is for positive statements. It will be reversible for negative statements. 
Antenatal Mothers  
      It refers to the women who all are pregnant from the time of conception to the 
term of pregnancy and attending antenatal checkups in selected private hospitals 
regularly.             
Cord blood stem cell therapy 
 Refers to meaning of Normal cell structure, Normal cell division, Definition, 
History, Types,Properties,Diseases treated by umbilical cord blood, Procedure, Nurses 
responsibilities of cord blood stem cells as stated in structured teaching programme.                                                   
ASSUMPTIONS 
The study assumes that; 
1. Antenatal mothers may have inadequate knowledge and attitude regarding cord blood 
stem cell therapy  
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2. Structured teaching programme can be an effective tool for creating awareness on 
knowledge and attitude regarding cord blood stem cell therapy. 
DELIMITATION  
1. The study is delimited to antenatal mothers only 
2. The study is delimited to six weeks only , 
3. The study is delimited to 30 samples only. 
4. The study is delimited to mothers who are all coming to selected private hospitals 
only. 
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CHAPTER - II 
REVIEW OF LITERATURE 
 Review of literature is a systematic search of literature to gain information about a 
research topic (Polit and Hungler).The literature review was based on an extensive survey 
of journal, books, and articles. 
 A literature review is body of text that aims to review the critical points of 
knowledge on a research and evaluate report of information found in the literature to 
evaluate and clarifies. The main purpose of the literature review is to convey the readers 
about the work already done and knowledge and ideas that have been already established 
on a particular topic of the research. 
 This chapter deals with the related literature review which aids to generate a 
picture of what is known and not known about a particular situation. 
 An extensive review of literature was done by the investigator to gain an insight 
into the problem, collect maximum information from systematic and critical review of 
scholarly publications, unpublished scholarly print materials. The logical sequence of the 
chapter is organized on the following sections: 
PART - I: REVIEW OF RELATED LITERATURE 
 The reviews related to the study are carried out on the following headings, 
 Literature related to knowledge and attitude regarding cord blood stem cell 
therapy. 
 Literature related to structured teaching programme on cord blood stem cell 
therapy. 
PART - II:  CONCEPTUAL FRAME WORK 
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PART - 1 
REVIEW OF LITERATURE 
Literature related to knowledge and attitude regarding cord blood stem cell therapy 
Hend S. Mohammed  and  Hend A. EL Sayed (2015)  conducted  a study on 
Knowledge and attitude of maternity nurses regarding cord blood collection and stem 
cells: An educational intervention . Quasi-experimental design (pre and post intervention) 
was utilized. A total sample of 53 staff nurses were recruited in the study. The study was 
conducted at two settings.  The results revealed that 88.7% of nurses had poor knowledge 
before intervention. However, 90.6% and 81.2% of them had good knowledge 
immediately and after three months of intervention respectively. As well as, only 1.9% of 
the studied nurses had positive attitude toward cord blood collection and stem cells 
before intervention. Meanwhile, immediately and after three months of intervention the 
positive attitude changed to 66.0% and 69.8% respectively. 
Tan et al., (2015) who conducted study on Knowledge and Attitude 
about Stem Cells and Their Application in Medicine among Nursing Students. Stem cell 
research has been extensively explored worldwide to enhance human health in medical 
setting. Nevertheless, there is currently no full understanding of the stem cell knowledge 
and attitude levels among student nurses in Malaysia. This study aimed to assess the level 
of stem cell knowledge, attitude toward stem cell application in medicine, and its 
association with years of education, among University Sains Malaysia (USM) 
undergraduate nursing students. A cross-sectional study (n = 88) was conducted using 
self-administered questionnaire consisted of demographic information, stem cells 
knowledge and attitude statements. Data was analyzed using Statistical Package Social 
Software 20.0. Results of the study shows that The majority of participants (92%) had 
moderate knowledge score about stem cells. Many students (33%) worried that stem cell 
application might cause a harm to humanity yet had a positive (76.1%) attitude towards 
its therapeutic potential (45.5%). Poor correlation between knowledge and attitude (r = 
0.08) indicated that acceptance towards stem cell is not solely based on the knowledge 
level but also on other factors including religion and culture. Conclusion reveals that this 
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study suggests that various educational programs on stem cell should be implemented 
considering the religion, cultural, social, and behavioral determinants in the population to 
improve stem cell knowledge and encourage a more positive attitude towards stem cells 
in medicine among these nursing students.  
Manal Farouk Moustafa1& Entisar Mohammad Youness (2015). Conducted a 
study on Nurses, Knowledge about Umbilical Cord Blood Banking and it's Barriers. Aim 
of the study was Researchers sought to assess nurses' knowledge regarding umbilical 
cord blood banking and identifying the barriers of it to be applied as their support is 
crucial to the success of development and functioning of cord blood banks in Women's 
Health Hospital, Assiut University Hospitals, Egypt. Research design used for this study 
was Descriptive study design was utilized in this study. Subjects and Methods are all 
nurses who work in Obstetrics and Gynecological department, Women's Health Hospital, 
Assiut University, Egypt, were included in the study between October 2014 and January 
2015. Data were collected in interviews by using an interview form developed by the 
researchers according to the literature. All nurses were 150. Results shows that nurses' 
Knowledge about UCBB are lacking , inadequate knowledge represented 79.7% and they 
identified from their point of view that the costs of the umbilical cord blood banks, 
policies and procedures are barriers of conducting such new technology in their hospitals. 
Conclusion and Recommendations: Nurses' level of knowledge on UCBB is inadequate 
and this indicates the necessity of creation of educational programs and continual training 
with the use of UCBB. Also nurses must be equipped to know the approved standards 
and understanding UCBB.  
Nevin Hotun Sahin and Husniye Dinç (2014) who conducted a study on 
pregnant women's knowledge and attitudes about stem cells and cord blood banking. 
Nurses need to understand stem cell research so they can enter the debate on this issue. 
They can become important sources of information in order to help parents understand 
the issues. This exploratory descriptive study was conducted in two antenatal outpatient 
clinics in Istanbul. The sample consisted of 334 pregnant women during routine prenatal 
visits. Data were collected in interviews by using an interview form developed by the 
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researchers according to the literature. The form included demographic characteristics of 
participants and 20 questions about stem cells, storing cord blood and banking and 10 
independent attitude statements. The majority of the participants had a lack of knowledge 
about stem cells and cord blood banking and wanted more information. Before 
pregnancy, they received some information through the media (newspaper, Internet, 
television, etc.), but unintentionally. It was determined that they wanted information 
before becoming pregnant, more from their obstetrician but also from nurses and 
midwives. The majority also wanted to store their infants' cord blood and stated that they 
would be more likely to choose a public cord blood bank. 
Kaitelidou et al., (2014) who conducted a study on Health Professionals‘ 
knowledge and attitude towards the Umbilical Cord Blood donation. The study was 
conducted from April 25th 2012 to May 7th 2012. The sample consisted of 109 Health 
Professionals from 3 provincial hospitals and 2 hospitals in Thessaloniki. In order to 
collect the data, a questionnaire was used. The questionnaire was designed by the 
researcher and a group of experts to serve the mission of the present study. From the 130 
questionnaires sent, 109 were completely answered (response rate 84%). Results shows 
that Of those who participated to the research, 23.9% were physicians, 34.9% were 
midwives, and 34.8% were nurses. As far as the Health Professionals‘ knowledge on the 
Umbilical Cord Blood is concerned, only 15.6% of the participants declared to be quite or 
well informed on the collection methods and the usage of Umbilical Cord Blood. The 
vast majority of the participants (89%), declared that a well-organized program on a 
continual training is very essential. 93.5% of the participants declared that in the last 5 
years received no or very little training regarding the collection, storing and 
transplantation of Umbilical Cord Blood. 
Xiang Hu et al., (2013) who conducted a study on Human umbilical cord blood 
stem cell transplantation for the treatment of chronic spinal cord 
injury: Electrophysiological changes and long-term efficacy. Results shows that Stem cell 
transplantation can promote functional restoration following acute spinal cord injury 
(injury time < 3 months), but the safety and long-term efficacy of this treatment need 
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further exploration. In this study, 25 patients with traumatic spinal cord injury (injury 
time > 6 months) were treated with human umbilical cord blood stem 
cells via intravenous and intrathecal injection. The follow-up period was 12 months after 
transplantation. Results found that autonomic nerve functions were restored and the latent 
period of somatosensory evoked potentials was reduced. There were no severe adverse 
reactions in patients following stem cell transplantation. These experimental findings 
suggest that the transplantation of human umbilical cord blood stem cells is a safe and 
effective treatment for patients with traumatic spinal cord injury. 
Bincy thomas (2012) who conducted a  study to assess the knowledge and 
preference among 1,000 cord blood donors and 300 pregnant women regarding donating 
umbilical cord blood to a public bank or storing it in a private bank in Italy. The study 
results shows that, most blood donors as well as the majority of pregnant women had 
some general knowledge about umbilical cord blood (UCB) 89% and 93% respectively 
and were aware of the possibility o donating it (82% and 95%). However the level of 
knowledge regarding current therapeutic use is generally low, only 91 (10%) among 
informed blood donors and 69 (31%) among informed pregnant women gone a correct 
answer. The study concluded that, preference for voluntary donation both among blood 
donors (76%) and among pregnant women (55%). But minority of blood donors (65%) 
and of pregnant women (9%) would opt to store UCB for private bank. 
Redid purnima   (2011) who conducted a study to assess the effectiveness of 
structured teaching program on knowledge and attitude regarding cord blood banking. 
Review shows some studies that include a study conducted to explore pregnant women‘s 
awareness of cord blood stem cells and their attitude regarding banking options in France, 
Germany, Italy, Spain, and the UK. The data were collected by using structured 
questionnaire. This questionnaire consist of 29 multiple –choice questions based on: 
socio-demographic factors, awareness and access to information about cord blood 
banking, banking option preference, and donation cord blood units (CBUs) to research. 
Questionnaires were distributed in six maternities. In this study a total of 79% of 
pregnant women had little awareness of cord blood banking 58%  of women had heard of 
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the therapeutic benefits of cord blood, of  which 21%  received information from 
midwifes and obstetricians. A total of 89% of respondents would opt to store CBUs. The 
first clinically documented use of cord blood stem cells was in the successful treatment of 
a six-year-old boy affected by Fanconi anemia in 1988. Since then, cord blood has 
become increasingly recognized as a source of stem cells that can be used in stem cell 
therapy. 
Shini SA (2011), A study was conducted on effectiveness of self instructional 
module on the knowledge regarding placental cord blood utilization and banking among 
staff nurses in selected hospitals in kasargoad, by approaching one group pre- test post -
test design. The sample consisted 60 staff nurses selected by convenient sampling and 
data was collected by using structured knowledge questionnaire. The result showed the 
difference suggesting that self- instructional was effective in increasing the knowledge of 
staff nurses (t=14.34). The mean post- test knowledge (x2=43.17) higher than the mean 
pre test knowledge (x1=30.40). There was association between the age and level of post 
test knowledge scores and in selected demographic variables. 
Redid purnima   (2011) who conducted a study to assess the effectiveness of 
structured teaching program on knowledge and attitude regarding cord blood banking. 
Review shows some studies that include a study conducted to explore pregnant women‘s 
awareness of cord blood stem cells and their attitude regarding banking options in France, 
Germany, Italy, Spain, and the UK. The data were collected by using structured 
questionnaire. This questionnaire consist of 29 multiple –choice questions based on: 
socio-demographic factors, awareness and access to information about cord blood 
banking, banking option preference, and donation cord blood units (CBUs) to research. 
Questionnaires were distributed in six maternities. In this study a total of 79% of 
pregnant women had little awareness of cord blood banking 58%  of women had heard of 
the therapeutic benefits of cord blood, of  which 21%  received information from 
midwifes and obstetricians. A total of 89% of respondents would opt to store CBUs. The 
first clinically documented use of cord blood stem cells was in the successful treatment of 
a six-year-old boy affected by Fanconi anemia in 1988. Since then, cord blood has 
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become increasingly recognized as a source of stem cells that can be used in stem cell 
therapy. 
Jeddian a  (2013)   who conducted a quality study on experiences of iranian 
hematopoietic stem cell transplantation recipient patients and nurses. This study explored 
the state of hematopoietic stem cell transplantation (hsct) recipient patients and problems 
experienced by them and nurse about these state and problems, in Iran. Qualitative 
content analysis was used for analyzing semi-structured interviews with 12 hsct recipient 
patients and 18 nurses. Results shows three main categories described the hsct state and 
problems: shadow of death, living with uncertainty, and immersion in problems. Patients 
treated with risk variety in continuity with probability of death. The patients lived with 
uncertainty. Consequently these resulted immersion in problems with four sub-categories 
including: (a) physical problems, (b) money worries, (c) life disturbances, and (d) 
emotional strain. Conclusion of the study hsct patients live in a state of limbo between 
life and death with multidimensional problems. Establish centers for supporting and 
educating of patients and their families, education of health care providers, enhancement 
of public knowledge about hsct along with allocating more budgets to take care of these 
patients can help patients for passing from this limbo. 
Literature related to structured teaching programme on cord blood stem cell 
therapy 
Walker .T et al (2012) A study was conducted to assess pregnant women‘s 
awareness of cord blood stem cells and their attitude regarding banking options among 
1620 pregnancy in women. France, Germany, Italy, UK. The study result showed that, 
total of 79% of pregnant women had little awareness of cord blood banking 59% of 
women had heard of the therapeutic benefits of cord blood, of which 21% received 
information from midwives and obstetricians, 89% of respondents would opt to store 
CBUs. Among them 76% would choose to donate CBUs to a public bank to benefit any 
patient in need of a cord blood transplant, 12%, a private bank. The study concluded that 
strong preference for public banking in all five countries. Attitudes of pregnant women 
are not a obstacle to the rapid expansion of allogenic banking in these EU countries. 
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Banking does not appear to be correlated with household income. The extent of 
commercial marketing of cord blood banks in mass media highlights the importance for 
obstetric providers to play a central role in raising women‘s awareness early during their 
pregnancy with evidence based medical information about banking options. 
Rosamund Scott ( 2012) conducted a ethnographic study that explored the views, 
values and practices of professional staff in relation to embryo donation for research 
purposes, particularly for hESC research. The study sites were three ACUs in teaching 
hospitals in England, which offer a mixture of National Health Service (NHS), privately, 
or ‗self-funded‘ NHS treatment, and three stem cell laboratories at the universities 
associated with these hospitals. The clinics provide a range of assisted conception 
services including in vitro fertilization (IVF). Following national and local research ethics 
committee approvals, the study methods included clinic and laboratory observations, 
interviews and ethics discussion groups (EDGs) (Alderson et al. 2002) with staff from 
ACUs and linked stem cell laboratories in the UK. Staff disciplines included nursing, 
obstetrics and gynecology, embryology, genetics, stem cell science, counseling and 
clinical and research management. Nurses in two ACUs and clinicians in the third ACU 
reported from here (at the times when our fieldwork took place) were responsible for 
discussing the initial HFEA consent forms. In two clinics donations for hESC research 
were not being sought at the time we commenced our interviews although they had been 
previously. 
Ruth Williams (2011) states that Neurons made from human embryonic stem 
cells (hESCs) can both send and receive nerve impulses when transplanted into the 
mouse brain, according to a report published on November in Proceedings of the National 
Academy of Sciences. The discovery provides some of the strongest evidence that hESC-
derived neurons, which could be used to treat a variety of neurological disorders such as 
epilepsy, stroke, and Parkinson‘s disease, can fully integrate and behave like regular 
neurons when transplanted into the brain. 
Mc Kernna D. et al (2011) a study was conducted to assess the umbilical cord 
blood, current status and promise for the future in India. The study results shows that, 
 17 
 
umbilical cord blood (UCB) have been shown to be a suitable source of hematopoietic 
stem cells (HSCs) for hematopoietic reconstitution. UCB increases in hematopoietic 
transplantation, additional potential application of UCB include immune therapy, tissue 
engineering and regenerative medicine. UCB banking has improved with time largely due 
to involvement of professional organization and their published standards. However 
accreditations of these organizations remains voluntary, and in India three of ten banks 
are public with the remaining being private. The study concluded that UCB banking 
using the stem cell for therapeutic use. 
Renece waller-wise (2011) states that Childbirth educators may be one of the 
main sources that an expectant family depends on to gain more knowledge about cord 
blood banking in order to make an informed decision. Preserving umbilical cord blood in 
public banks is advisable for any family; however, it is recommended that expectant 
families only consider private cord blood banking when they have a relative with a 
known disorder that is treatable by stem cell transplants. The childbirth educator is 
encouraged to be well versed on the topic of cord blood banking, so that as questions 
from class participants arise, the topic can be explored and addressed appropriately. 
Randy Louis Regna (2010) states Stem cells can be pluripotent or multipotent. 
Pluripotent stem cells are embryonic in origin and can be isolated from embryos ranging 
from a few days old to 8 weeks of fetal development. Embryonic stem cells arising from 
a blastocyst are comprised of 50 to 150 cells and have the greatest potential to develop 
into 200 cell types. Adult stem cells are the only stem cells commonly used to treat 
human disease. Successful treatments have been demonstrated through bone marrow 
transplants for leukemia, lymphoma, aplastic anemia and other blood and autoimmune 
disorders. Clinical potential exists in the treatment of diabetes and advanced kidney 
cancers. 
Reetu hanglem  (2010)  states that in 1988, umbilical cord stem cells were first 
used for transplantation on a 5-year old boy suffering from Fanconi's anaemia in France. 
The boy was cured of the disease and is still alive. Based on this and other successful 
transplants, doctors and researchers began to collect, freeze and store cord blood units at 
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cord banks throughout the world to treat several ailments and save lives. More than 45 
diseases have now been treated using cord blood cells. These include malignant diseases 
like leukaemia, lymphoma, neuroblastoma and retinoblastoma, and several other non-
malignant diseases as well. Non- malignant diseases are primarily inherited disorders of 
the blood and immune systems, or are genetic diseases affecting metabolism.
 
 There have 
been over 15,000 cord blood transplants worldwide through 2009. In the United States, 
more than one half of all stem cell transplants from unrelated donors in children now use 
cord blood. In Japan, this is true for adults as well. This program has provided cord blood 
units for transplantation to over 3,500 recipients to date, about one fourth of all cord 
blood transplants from unrelated donors.
 
  In India, there are approximately 72000 births 
daily, which results in discarding 72000 umbilical cords a day. The storage of stem cell 
rich blood derived from these umbilical cords can prove to be the best possible insurance 
against life threatening diseases.
8.
Indians have high incidence of diseases like Diabetes 
and Heart ailments, in the treatment of which cord blood can be a godsend, The potential 
of these stem cells are far higher because they prevent Graft versus Host Disease. 
Cedar SH.(2009) states that  Nurses and midwives are part of health care in all 
the stages of our lives from preconception to death. Recent scientific advances have 
introduced new techniques of screening and diagnosis linked to stem cell isolation and 
therapies. These could affect us at any age and therefore nurses will be involved as 
careers and patients advocates for these techniques. In this article stem cell techniques 
and therapies are outlined, as well as some of the ethical challenges faced by various 
nursing groups, whether in adult, learning difficulties, mental health, paediatric, primary 
care, public health or health visiting areas.  Nurses represent all parties in these therapies 
and act as advocates for every patient group. They need to act in an interprofessional 
environment to promote the best interests of all their clients, both clinically and ethically. 
Gregory Hale, (2009) conducted a study on Haploidentical Stem Cell Transplant 
for Treatment Refractory Hematological Malignancies haploidentical transplant has 
proven curative in many patients, this procedure has been hindered by significant 
complications, primarily regimen-related toxicity including graft versus host disease 
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(GVHD), and infection due to delayed immune reconstitution. These can, in part, be due 
to certain white blood cells in the graft called T cells. GVHD happens when the donor 
T cells recognize the patient's (the host) body tissues are different and attack these cells. 
Although too many T cells increase the possibility of GVHD, too few may cause the 
recipient's immune system to reconstitute slowly or the graft to fail to grow, leaving the 
patient at high-risk for infection. However, the presence of T cells in the graft may offer a 
positive effect called graft versus malignancy or GVM. With GVM, the donor 
T cells recognize the patient's malignant cells as diseased and, in turn, attack these 
diseased cells. In this study, patients were given a haploidentical graft engineered to with 
specific T cell parameter values using the CliniMACS system. A reduced intensity, 
preparative regimen was used to reduce regimen-related toxicity and mortality. The 
primary goal of this study is to evaluate overall survival in those who receive this study 
treatment. 
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PART II 
CONCEPTUAL FRAMEWORK 
The word conceptual framework represents a less formal attempt at organizing a 
phenomenon. Conceptual model deals with concepts that are used as building blocks and 
provide a conceptual perspective regarding inter related phenomena which are closely 
structured.  
The central focus of Imogene King‘s framework is man as a dynamic human 
being whose perception of objects, person and events influence his behavior, social 
interaction, and health. Imogene King‘s conceptual frame work includes three interacting 
system which each system having its own distinct group of concepts and characteristics. 
These systems include personal system, interpersonal system and social system. King‘s 
basic assumption maintained that nursing is a process that involves caring for human 
beings which health being the ultimate goal (Torres,1986) the three system that constitute 
King‘s conceptual framework provide the basis for development of her theory of goal 
attainment.  
The personal system refers to the individual. The concept within the personal 
system and fundamental in understanding human beings are perception, self, body image, 
growth and development, time and space. Imogene King viewed perception as the most 
important variables because perception influences behavior. King summarized the 
connections among the concepts in the following statement. An individual‘s perception of 
self, body image, time and space influence the way he or she responds to persons, objects 
and events in his or her life. As individuals grow and develop through the life span, 
experiences with changes in structure and function of their bodies over time influence 
their perception of self, interpersonal systems involve individuals interacting with one 
another.  
Imogene king (1981) stated, although personal and social systems influence the 
quality of care, the major elements in a theory of goal attainment are discovered in the 
interpersonal system in which two people, who are usually strangers, come together 19 in 
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a health care organization to help and to be helped to maintain a state of health that 
permits functioning in roles. King believed that interactions between the nurse and 
mothers results in goal attainment.  
This theory is based on the concepts of the personal and interpersonal systems 
including interaction, perception, transaction and action. A basic theory for conceptual 
framework, which is aimed to assess the effectiveness of structured teaching programme 
on knowledge and attitude regarding stem cell therapy among antenatal mothers. The 
major concepts are described as follows. 
1. Perception  
Perception is the person‘s representation of the reality. It influences all other 
behavior of a person and it is more subjective and unique to each person. The researcher 
perceives that the antenatal mothers have inadequate of knowledge and poor attitude 
regarding cord blood stem cell therapy.  
2. Judgement  
The judgment is a decision made by the researcher and the antenatal mothers. 
Here the researcher judges that teaching the antenatal mothers regarding cord blood stem 
cell therapy.  
3. Action  
It refers to the changes that have to be achieved. The researcher‘s action is 
planned and motivated to conduct structured teaching programme on knowledge and 
attitude on cord blood stem cell therapy among antenatal mothers. 
4. Mutual goal setting  
Here the researcher educate structured teaching programme on cord blood stem 
cell therapy and the antenatal mothers are actively involved in this programme.  
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 5. Reaction  
Reaction means decision to act. In this study the researcher developed a tool to 
assess the existing knowledge and attitude regarding cord blood stem cell therapy among 
antenatal mothers.  
6. Interaction  
Interaction is a process of perception and communication between person to 
person, represented by verbal and nonverbal behaviors that are goal directed. Here the 
researchers gave pretest conducted structured teaching programme on knowledge and 
attitude on cord blood stem cell therapy among antenatal mothers and post test.  
7. Transaction  
The transaction is purposeful interaction that leads to goal attainment, between the 
researcher and the antenatal mothers. Here the researcher assesses the effectiveness of 
structured teaching programme on knowledge and attitude regarding cord blood stem cell 
therapy by post test by using the same tool.  
Positive outcome is adequate knowledge and attitude regarding cord blood stem 
cell therapy among antenatal mothers which has to be enhanced further. Negative 
outcome is moderate and inadequate knowledge and attitude regarding cord blood stem 
cell therapy among antenatal mothers.  
King‘s conceptual framework provides a useful structure for the researcher, in 
educating antenatal mothers regarding cord blood stem cell therapy. This theory also 
provides direction for nursing practice by emphasizing the process of multidisciplinary 
collaboration, communication, interaction, transaction and the use of critical thinking. 
Thus the researcher adopted this model to assess the effectiveness of structured teaching 
programme on knowledge and attitude regarding cord blood stem cell therapy among 
antenatal mothers. 
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Fig. 1 Conceptual Framework Based on Modified Imogene King‟s Goal Attainment 
Model
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CHAPTER - III 
RESEARCH METHODOLOGY 
 Methodology of research organizes all the components of study in a way that 
most likely we need to valid answers for the problems that have been posted. 
(Burns and Groove, 2008) 
This chapter deals with the methodology adopted for the study. It includes the 
research approach, research design, variables, setting, population, sample and criteria for 
selection of the sample, sample size, sampling technique, development and description of 
the tool, content validity, pilot study and reliability of the tool, data collection procedure 
and plan for data analysis. 
RESEARCH APPROACH: 
  A evaluative research approach has been used for the study.  
RESEARCH DESIGN:  
The research design used in this study was pre experimental one group pretest 
post test research design.  
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The schematic representation follows 
Group 
 
Pre-test 
(01) 
Intervention 
           () 
Post-test 
(02) 
Antenatal mothers Assessment of pre 
test level of 
knowledge and 
attitude regarding 
cord blood stem cell 
therapy. 
 
Structured teaching 
programme  
On knowledge and 
attitude regarding 
cord blood stem cell 
therapy. 
 
 
Assessment of post  
test level of knowledge 
and attitude regarding 
cord blood stem cell 
therapy. 
 
VARIABLES 
 Dependent variable  
 The dependent variables in this study are knowledge and attitude. 
Independent variable  
The independent variable in this study is structured teaching programme on cord 
blood stem cell therapy. 
Extraneous Variable  
The extraneous variables in this study are educational status, occupation, income. 
SETTING 
 The research setting was Jayaa hospital and Suguna hospital, Tiruchengode, 
Namakkal district, Each hospital consist of 100 bedded hospitals.  
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POPULATION  
Target Population 
The target population for this study was antenatal mothers.  
Accessible Population 
Antenatal mothers in Jayaa hospital and Suguna hospital at Tiruchengode. 
SAMPLE  
The sample for this study included antenatal mothers who meet inclusive criteria.  
SAMPLE SIZE  
It consists of 30 antenatal mothers. Samples were selected from Jayaa and Suguna 
hospitals, Tiruchengode.  
CRIETERIA FOR SAMPLE SELECTION 
Inclusion criteria 
The study include 
 Antenatal Mothers who attend Outpatient department in selected private 
hospitals at Namakkal district.  
 Mothers who are willing to participate in the study 
 Mothers who are available at the time of data collection 
 Mothers parents are able to read and write. 
  Mothers who are educated. 
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Exclusion criteria 
 The study excludes, 
 Mothers who are all having any hearing and visual problem. 
 Mothers who already registered for cord blood stem cell therapy. 
SAMPLING TECHNIQUE  
Thirty (30) antenatal mothers were selected by non probability convenient 
sampling technique from Jayaa and Suguna hospitals, Tiruchengode. 
DEVELOPMENT AND DESCRIPTION OF TOOL  
The tool is a vehicle that could obtain data pertinent to the study and at the same 
time adds to the body of general knowledge in the discipline. Data collection tools were 
used by the researcher to observe or measure the key. Selection and development of the 
tool was done based on the objectives of the study. After the review of related literatures 
the structured knowledge and attitude interview questionnaire regarding cord blood stem 
cell therapy among antenatal mothers was developed by the investigator. The developed 
tool was refined and validated by the subject experts and guide.  
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       Fig: 2 SCHEMATIC REPRESENTATION OF RESEARCH 
METHODOLOGY 
 
EVALUATIVE APPROACH 
RESEARCH DESIGN: Pre Experimental One Group, Pretest and Post Test Design 
STUDY SETTING: Jayaa and suguna Hospitals at Tiruchengode. 
TARGET POPULATION: Antenatal Mothers. 
ACCESSIBLE POPULATION:  
Antenatal Mothers Who Meet Inclusive Criteria. 
SAMPLING TECHNIQUE: Non probability convenient sampling Technique. 
PRE TEST: Assessment Of Knowledge And Attitude Regarding cord blood stem cell 
therapy among Antenatal Mothers. 
INTERVENTION: Structured Teaching Programme on cord blood stem cell therapy 
among Antenatal Mothers 
POST TEST :  Assessment Of effectiveness of structured teaching programme on 
cord blood stem cell therapy among Antenatal Mothers. 
 
DATA ANALYSIS: Descriptive And Inferential Statistics. 
FINDINGS AND CONCLUSION 
SAMPLE SIZE: 30 
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DATA COLLECTION TOOL  
The tool consists of three sections  
SECTION – A  
It deals with demographic variables,which includes Age,Religion,Gravida, 
Education,Occupation,Types of family,Previous source on stem cell therapy. 
SECTION – B  
This section consists of structured questionnaire to assess the knowledge among 
antenatal mothers. It consists of 40 multiple choice questions. Scoring was done for each 
items. In each question there was only one right choice. Each correct answer was given a 
score of one and wrong answer carries score of zero. Knowledge was measured in terms 
of knowledge score. The total scores of knowledge were 40.  
Scoring key each correct answer carries – 1 mark  
Each incorrect answer carries – 0 mark,  
and it is classified as  
Score   level of knowledge  
 
≤50%    Inadequate Knowledge 
 
51 – 75%                                      Moderately Adequate Knowledge 
 
>75%    Adequate Knowledge 
SECTION - C  
A likert attitude scale was prepared by the investigator to assess the attitude of 
stem cell therapy among antenatal mothers. It consists of 20 statements that are 16 
positive statement and 4 negative statements. Each statement was scored in the following 
manner.  
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Scoring key  
Each item has 5 options such as Strongly Agree, Agree, Neither Agree nor 
Disagree, Disagree, Strongly Disagree. 
The scores for those who strongly agree 5 points, 4 points for agree, 3 points for neither 
Agree nor Disagree, 2 points for disagree, 1 point for Strongly Disagree.  
 This is for positive statements. It will be reversible for negative statements. 
Score   Attitude Level  
≤50%    Favorable attitude 
51 – 75%                                      Moderately Favorable attitude 
>75%    Unfavorable attitude 
 
INTERVENTION 
 Structured teaching programme on cord blood stem cell therapy among antenatal 
mothers.  
CONTENT VALIDITY 
Polit and hungler (1999) stated that it is concerned that sampling adequacy of 
items for the construct that is being measured. Content validity is relevant for both 
affective measures and cognitive measures. The content validity of an instrument is 
necessarily based on judgment. The content validity of tool was done by 3 nursing 
experts, 2 obstetricians and gynecologist. Experts were asked to give their opinion and 
suggestions about the concept of the tool. The modifications recommended by the experts 
were incorporated in the final preparation of the questionnaire by the investigator. The 
tool was translated into Tamil by language experts.  
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RELIABILITY  
Polit and Hungler (1999) state that one important characteristics of measuring tool 
is its reliability, which refers to the degree of consistency or accuracy with which an 
instrument measures an attribute. The structured interview questionnaire was tried on 30 
antenatal mothers selected in Jayaa and Suguna hospitals Tiruchengode at Namakkal 
district. Reliability was found out by split half method using spearman Brown‘s formula. 
The reliability of the knowledge questionnaire was found to be r = 0.83 and for attitude 
r= 0.87 Hence the tool was found to be statistically reliable for the study.  
PILOT STUDY  
Pilot study is a trial run for major study to test the reliability, practicability, 
appropriateness and flexibility of the tool for the study. The investigator conducted a pilot 
study in the month of January with 5 samples selected in Raji hospital Tiruchengode at 
Namakkal district. The data was analyzed by using descriptive statistics that is mean, 
percentage and standard deviation of the variables and were calculated and compared. 
Results revealed that there was a positive correlation. The tool was found feasible and 
practicable. The investigator proceeded for the main study. No modification was done in 
the methodology and tool.  
PROCEDURE FOR DATA COLLECTION  
 The main study was conducted after obtaining formal permission from the 
principal,Arvinth College of Nursing, Ethical Committee clearance and written 
permission was obtained from the doctors of Jayaa and Suguna hospital,Tiruchengode, 
Namakkal district. 
 A total of 30 Antenatal mothers who fulfilled the inclusive criteria were selected 
using non probability convenient sampling technique. The data was collected during the 
month of February 2016. 
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 A brief introduction of self explanation on the purpose of the study was given. 
The written consent was obtained from the antenatal mothers. 
 The investigator collected socio demographic data and assessed their knowledge 
and attitude on cord blood stem cell therapy on first day and structured teaching 
programme on cord blood stem cell therapy among antenatal mothers was given on the 
same day for 45 minutes to 1 hour. Post test knowledge and attitude was assessed on 8
th 
day by using same tool as used for the pre test. 
No of samples Date of Pre test Date of post test 
7 03/02/2016 10/02/2016 
4 04/02/2016 11/02/2016 
3 05/02/2016 12/02/2016 
6 06/02/2016 13/02/2016 
5 07/02/2016 14/02/2016 
5 08/02/2016 15/02/2016 
 
PLAN FOR DATA ANALYSIS   
 The data obtained were analyzed using both descriptive and inferential 
statistics.   
 Descriptive statistics used to find out frequency, percentage, mean and 
standard deviation.   
 ―t‟ test was used for comparing the knowledge and attitude. 
 Correlation was used to find out the relationship between knowledge and 
attitude among ante natal mothers.   
 Chi-square test was used to find out the association of demographic variable 
with knowledge and attitude. 
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CHAPTER – IV  
DATA ANALYSIS AND INTERPRETATION 
 
This chapter deals with the analysis and interpretation of data collected from 
30 antenatal mothers in selected private hospitals at Namakkal District, to assess the 
effectiveness of Structured Teaching Programme on knowledge and attitude regarding 
cord blood stem cell therapy among antenatal mothers. The data collected for the 
study was grouped and analyzed as per the objectives set for the study. The findings 
based on the descriptive and inferential statistical analysis are presented under the 
following sections. 
ORGANIZATION OF DATA 
The findings of the study were grouped and analyzed under the following 
sessions. 
Section A : Description of the demographic variables. 
Section B : Assessment of pretest and post test level of knowledge and attitude 
regarding cord blood stem cell therapy among antenatal mothers. 
Section C : Effectiveness of structured teaching programme on knowledge and 
attitude regarding cord blood stem cell therapy among antenatal 
mothers. 
Section D : Relationship between post test knowledge and attitude scores regarding 
cord blood stem cell therapy among antenatal mothers. 
Section E : Association of post test level of knowledge and attitude regarding cord 
blood stem cell therapy among antenatal mothers with selected 
demographic variables. 
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SECTION A: DESCRIPTION OF THE DEMOGRAPHIC VARIABLES. 
Table 1: Frequency and percentage distribution of demographic variables of 
antenatal mothers          
n = 30 
Demographic Variables No. % 
Age of the mother     
21 – 25 10 33.33 
26 – 30 15 50.00 
31 – 35 3 10.00 
36 – 40 2 6.67 
Religion     
Hindu 25 83.33 
Muslim 3 10.00 
Christian 2 6.67 
Others 0 0.00 
Gravida of the mother     
Gravida one 16 53.33 
Gravida two 14 46.67 
Multigravida 0 0.00 
Education     
Secondary school education 1 3.33 
Higher secondary education 9 30.00 
Graduate 20 66.67 
Occupation     
Homemaker 5 16.67 
Government employee 6 20.00 
Private employee 13 43.33 
Self - employee business 6 20.00 
Type of family     
Nuclear family 13 43.33 
Joint family 17 56.67 
Previous knowledge     
Mass media 5 16.67 
Health workers 0 0.00 
Peer group 0 0.00 
None 25 83.33 
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The table 1 shows that majority 15(50%) of antenatal mothers were in the age 
group of 26 – 30 years, 25983.33%) were Hindus, 16(53.33%) were gravida one, 
20(66.67%) were graduates, 13(43.33%) were private employee, 17(56.67%) 
belonged to joint family and 25(83.33%) had no previous knowledge on cord blood 
stem cell therapy.   
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SECTION B: ASSESSMENT OF PRETEST AND POST TEST LEVEL OF 
KNOWLEDGE AND ATTITUDE REGARDING CORD BLOOD STEM CELL 
THERAPY AMONG ANTENATAL MOTHERS. 
Table 2: Frequency and percentage distribution of pretest and post test level of 
knowledge regarding cord blood stem cell therapy among antenatal mothers. 
n = 30 
Knowledge 
Inadequate 
(≤50%) 
Moderately 
Adequate 
(51 – 75%) 
Adequate 
(>75%) 
No. % No. % No. % 
Pretest 30 100.0 0 0 0 0 
Post Test 0 0 7 23.33 23 76.67 
 
The table 2 shows that in the pretest, almost all 30(100%) had inadequate 
knowledge whereas in the post test after imparting structured teaching programme 
majority 23(76.67%) had adequate knowledge and only 7(23.33%) had moderately 
adequate knowledge regarding cord blood stem cell therapy among antenatal mothers. 
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Fig :3 Percentage distribution of pretest and post test level of knowledge regarding cord blood stem cell therapy among antenatal 
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Table 3: Frequency and percentage distribution of pretest and post test level of 
attitude regarding cord blood stem cell therapy among antenatal mothers. 
n = 30 
Attitude 
Unfavourable 
(<50%) 
Moderately 
Favourable 
(50 – 75%) 
Favourable 
(>75%) 
No. % No. % No. % 
Pretest 25 83.33 5 16.67 0 0 
Post Test 3 10.0 6 20.0 21 70.0 
 
 
The table 3 shows that in the pretest, almost all 25(83.33%) had unfavourable 
attitude and 5(16.67%) had moderately favourable attitude whereas in the post test after 
imparting structured teaching programme majority 21(70%) had favourable attitude, 
6(20%) had moderately favourable attitude and 3(10%) had unfavourable attitude 
regarding cord blood stem cell therapy among antenatal mothers. 
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Fig : 4 Percentage distribution of pretest and post test level of attitude regarding cord blood stem cell therapy among antenatal mothers 
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SECTION C: EFFECTIVENESS OF STRUCTURED TEACHING PROGRAMME 
ON KNOWLEDGE AND ATTITUDE REGARDING CORD BLOOD STEM 
CELL THERAPY AMONG ANTENATAL MOTHERS. 
Table 4: Comparison of pretest and post test knowledge scores regarding cord blood 
stem cell therapy among antenatal mothers. 
n = 30 
Knowledge Mean S.D Paired „t‟ Value 
Pretest 11.50 2.70 t = 57.742 
p = 0.000, S*** Post Test 33.06 3.93 
***p<0.001, S – Significant 
 
 The table 4 shows that in the pretest, the mean score of knowledge was 11.50 with 
S.D 2.70 whereas in the post test the mean score of knowledge was 33.06 with S.D 3.93. 
The calculated paired ‗t‘ value of t = 57.742 was found to statistically significant at 
p<0.001 level. This clearly shows that the structured teaching programme imparted to 
antenatal mothers had significant improvement in the post test level of knowledge 
regarding cord blood stem cell therapy. 
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Table 5: Comparison of pretest and post test attitude scores regarding cord blood 
stem cell therapy among antenatal mothers. 
n = 30 
Attitude Mean S.D Paired „t‟ Value 
Pretest 40.26 11.98 t = 18.758 
p = 0.000, S*** Post Test 78.40 14.31 
***p<0.001, S – Significant 
 
The table 5 shows that in the pretest, the mean score of attitude was 40.26 with 
S.D 11.98 whereas in the post test the mean score of knowledge was 78.40 with S.D 
14.31. The calculated paired ‗t‘ value of t = 29.885 was found to statistically significant 
at p<0.001 level. This clearly shows that the structured teaching programme imparted to 
antenatal mothers had significant improvement in the post test level of attitude regarding 
cord blood stem cell therapy. 
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SECTION D: RELATIONSHIP BETWEEN POST TEST KNOWLEDGE AND 
ATTITUDE SCORES REGARDING CORD BLOOD STEM CELL THERAPY 
AMONG ANTENATAL MOTHERS. 
Table 6: Correlation between post test knowledge and attitude scores regarding 
cord blood stem cell therapy among antenatal mothers. 
n = 30 
Variables Mean S.D „r‟ Value 
Knowledge 33.06 3.93 r = 0.715 
p = 0.000, S** Attitude 78.40 14.31 
**p<0.01, S – Significant 
 
 The table 6 shows that the post mean score of knowledge was 33.06 with S.D 3.93 
and the posttest attitude score was 78.40 with S.D 14.31. The calculated Karl Pearson‘s 
Correlation value of r = 0.715 shows a positive correlation and it was found to be 
statistically significant at p<0.01 level. This clearly indicates that when the knowledge 
regarding cord blood stem cell therapy among antenatal mothers increases their attitude 
level also increases. 
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SECTION E: ASSOCIATION OF POST TEST LEVEL OF KNOWLEDGE AND 
ATTITUDE REGARDING CORD BLOOD STEM CELL THERAPY AMONG 
ANTENATAL MOTHERS WITH SELECTED DEMOGRAPHIC VARIABLES. 
Table 7: Association of post test level of knowledge regarding cord blood stem cell 
therapy among antenatal mothers with selected demographic variables. n = 30 
Demographic Variables 
Moderately 
Adequate 
(51 – 75%) 
Adequate 
(>75%) 
Chi-
Square 
Value 
No. % No. % 
Age of the mother 
 
 
 
 
2=1.118 
d.f=3 
p = 0.773 
N.S 
21 – 25 3 10.0 7 23.3 
26 – 30 3 10.0 12 40.0 
31 – 35 1 3.3 2 6.7 
36 – 40 0 0 2 6.7 
Religion 
 
 
 
 
2=0.783 
d.f=2 
p = 0.676 
N.S 
Hindu 0 0 19 63.3 
Muslim 1 3.3 2 6.7 
Christian 0 0 2 6.7 
Others - - - - 
Education 
 
 
 
 2=0.932 
d.f=2 
p = 0.628 
N.S 
Secondary school education 0 0 1 3.3 
Higher secondary education 3 10.0 6 20.0 
Graduate 4 13.3 16 53.3 
Occupation 
 
 
 
 
2=0.932 
d.f=3 
p = 0.818 
N.S 
Homemaker 2 6.7 3 10.0 
Government employee 1 3.3 4 13.3 
Private employee 3 10.0 12 40.0 
Self - employee business 1 3.3 4 13.3 
Type of family 
 
 
 
 
2
=0.001 
d.f=1 
p = 0.977 
N.S 
Nuclear family 3 10.0 10 33.3 
Joint family 4 13.3 13 43.3 
Previous knowledge 
 
 
 
 
2=0.932 
d.f=1 
p = 0.334 
N.S 
Mass media 2 6.7 3 10.0 
Health workers - - - - 
Peer group - - - - 
None 5 16.7 20 66.7 
*p<0.05, S – Significant, N.S – Not Significant 
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The table 7 shows that the demographic variable gravida had shown statistically 
significant association with post test level of knowledge regarding cord blood stem cell 
therapy among antenatal mothers at p<0.05 level and the other demographic variables 
had not shown statistically significant association with post test level of knowledge 
regarding cord blood stem cell therapy among antenatal mothers.  
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Table 8: Association of post test level of attitude regarding cord blood stem cell 
therapy among antenatal mothers with selected demographic variables.  
            n = 30 
Demographic Variables 
Unfavourable 
(≤50%) 
Moderately 
Favourable 
(50 – 75%) 
Favourable 
(>75%) 
Chi-Square 
Value 
No. % No. % No. % 
Age of the mother   
 
 
 
 
2=2.595 
d.f=6 
p = 0.858 
N.S 
21 – 25 1 3.3 3 10.0 6 20.0 
26 – 30 2 6.7 2 6.7 11 36.7 
31 – 35 0 0 1 3.3 2 6.7 
36 – 40 0 0 0 0 2 6.7 
Religion   
 
 
 
 
2=1.543 
d.f=4 
p = 0.819 
N.S 
Hindu 3 10.0 5 16.7 17 56.7 
Muslim 0 0 1 3.3 2 6.7 
Christian 0 0 0 0 2 6.7 
Others - - - - - - 
Education   
 
 
 
 2=0.476 
d.f=4 
p = 0.976 
N.S 
Secondary school education 0 0 0 0 1 3.3 
Higher secondary education 1 3.3 2 6.7 6 20.0 
Graduate 2 6.7 4 13.3 14 46.7 
Occupation   
 
 
 
 
2=7.436 
d.f=6 
p = 0.282 
N.S 
Homemaker 1 3.3 2 6.7 2 6.7 
Government employee 1 3.3 0 0 5 16.7 
Private employee 0 0 4 13.3 9 30.0 
Self - employee business 1 3.3 0 0 5 16.7 
Type of family   
 
 
 
 
2
=1.008 
d.f=2 
p = 0.604 
N.S 
Nuclear family 2 6.7 3 10.0 8 26.7 
Joint family 1 3.3 3 10.0 13 43.3 
Previous knowledge   
 
 
 
 
2=1.886 
d.f=2 
p = 0.390 
N.S 
Mass media 0 0 2 6.7 3 10.0 
Health workers - - - - - - 
Peer group - - - - - - 
None 3 10.0 4 13.3 18 60.0 
N.S – Not Significant 
 46 
 
The table 8 shows that none of the demographic variables had shown statistically 
significant association with post test level of attitude regarding cord blood stem cell 
therapy among antenatal mothers. 
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CHAPTER - V 
DISCUSSION 
This chapter discusses in detail the findings of the study derived from the 
statistical analysis and its pertinence to the objectives of the study and further discussion 
exemplify these objectives were satisfied by the study.The purpose of the study was to 
assess the effectiveness of structured teaching programme on knowledge and attitude 
regarding cord blood stem cell therapy among antenatal mothers. The findings based on 
the descriptive and inferential statistical analysis are presented under the following 
sections. 
Description of the demographic variable among antenatal mothers with cord blood 
stem cell therapy 
With regard to the demographic variables majority 15(50%) of antenatal mothers 
were in the age group of 26 – 30 years, 25983.33%) were Hindus, 16(53.33%) were 
gravida one, 20(66.67%) were graduates, 13(43.33%) were private employee, 
17(56.67%) belonged to joint family and 25(83.33%) had no previous knowledge on cord 
blood stem cell therapy.   
The first objective was to determine the pretest and posttest level of knowledge and 
attitude regarding cord blood stem cell therapy among antenatal mothers 
Findings of  pretest, almost all 30(100%) had inadequate knowledge whereas in 
the post test after imparting structured teaching programme majority 23(76.67%) had 
adequate knowledge and only 7(23.33%) had moderately adequate knowledge regarding 
cord blood stem cell therapy among antenatal mothers. 
The finding also revealed that in the pretest, almost all 25(83.33%) had 
unfavourable attitude and 5(16.67%) had moderately favourable attitude whereas in the 
post test after imparting structured teaching programme majority 21(70%) had favourable 
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attitude, 6(20%) had moderately favourable attitude and 3(10%) had unfavourable 
attitude regarding cord blood stem cell therapy among antenatal mothers. 
The second objective was to assess the effectiveness of structured teaching 
programme on knowledge and attitude regarding cord blood stem cell therapy 
among antenatal mothers. 
The comparison tables  showed that in the pretest, the mean score of knowledge 
was 11.50 with S.D 2.70 whereas in the post test the mean score of knowledge was 33.06 
with S.D 3.93. The calculated paired ‗t‘ value of t = 57.742 was found to statistically 
significant at p<0.001 level. This clearly shows that the structured teaching programme 
imparted to antenatal mothers had significant improvement in the post test level of 
knowledge regarding cord blood stem cell therapy. 
The table 5 shows that in the pretest, the mean score of attitude was 40.26 with 
S.D 11.98 whereas in the post test the mean score of knowledge was 78.40 with S.D 
14.31. The calculated paired ‗t‘ value of t = 29.885 was found to statistically significant 
at p<0.001 level. This clearly shows that the structured teaching programme imparted to 
antenatal mothers had significant improvement in the post test level of attitude regarding 
cord blood stem cell therapy. 
Hence the hypothesis H1- There will be significant difference between pre and 
post test knowledge and attitude score regarding cord blood stem cell therapy among 
antenatal mothers. 
The third objectives was to relationship between post test knowledge and attitude 
scores regarding cord blood stem cell therapy among antenatal mothers. 
The table 6 shows that the post mean score of knowledge was 33.06 with S.D 3.93 
and the posttest attitude score was 78.40 with S.D 14.31. The calculated Karl Pearson‘s 
Correlation value of r = 0.715 shows a positive correlation and it was found to be 
statistically significant at p<0.01 level. This clearly indicates that when the knowledge 
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regarding cord blood stem cell therapy among antenatal mothers increases their attitude 
level also increases. 
Hence the hypothesis H2- There will be significant association between post test 
knowledge and attitude score with selected demographic variables such as (Age, 
Religion, Gravida, Education, Previous source on cord blood stem cell therapy) 
The fourth objective was to associate the post test level of knowledge and attitude 
regarding cord blood stem cell therapy among antenatal mothers with selected 
demographic variables. 
Table 7 shows that all demographic variables had not shown statistically 
significant association with post test level of knowledge regarding cord blood stem cell 
therapy among antenatal mothers at p<0.05 level. 
The table 8 shows that none of the demographic variables had shown statistically 
significant association with post test level of attitude regarding cord blood stem cell 
therapy among antenatal mothers. 
Hence the hypothesis H3-There will be relationship between post test knowledge 
and attitude with selected demographic variables such as (Age, Religion, Gravida, 
Education, Previous source on cord blood stem cell therapy). 
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CHAPTER - VI 
SUMMARY, CONCLUSION, NURSING IMPLICATIONS, 
RECOMMENDATIONS AND LIMITATIONS 
This chapter presents the summary, conclusion, nursing implications, 
recommendations and limitations of the study based on objectives selected. 
SUMMARY 
The umbilical cord is one of the richest sources of pure young stem cells in the 
human body. Stem cells are the very foundation of the human body. Every part of our 
body including blood, bone, skin and muscles are formed from master cells known as 
stem cells. Cord blood stem cells are master cells of our body used in the treatment of 
nearly 80 diseases, including wide range of cancers, genetic diseases and blood 
transplant. When a transplant is successful a healthy new immune system has been 
treated.Umblical cord stem cells when preserve under cryogenic conditions have no 
expiration date, thereby providing life time benefit. 
 
The objectives of the study were 
1. To assess the pre test knowledge and attitude regarding cord blood stem cell  
    therapy among antenatal mothers.   
2. To assess the effectiveness of structured teaching programme on cord blood  
    stem cell therapy among antenatal mothers. 
3. To correlate knowledge and attitude regarding cord blood stem cell therapy   
   among antenatal mothers  
4. To find the association between post test knowledge and attitude regarding 
    stem cell therapy among antenatal mothers with their selected demographic cell  
   variables such as Age ,Religion, Gravida, Education, Previous source on cord  
   blood stem therapy. 
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The study was based on assumptions that  
The study assumes that;  
1. Antenatal mothers may have inadequate knowledge and    attitude regarding  
   cord blood stem cell therapy  
2. Structured teaching programme can be an effective tool for creating awareness  
    on knowledge and attitude regarding cord blood stem cell therapy. 
The hypothesis formulated were 
 H1- There will be significant difference between pre and post test knowledge 
and attitude score regarding cord blood stem cell therapy among antenatal 
mother. 
 
 H2- There will be significant association between post test knowledge and   
attitude score with selected demographic variables such as (Age, Religion, 
Gravida, Education, Previous source on cord blood stem cell therapy) 
 
 H3-There will be relationship between post test knowledge and attitude with 
selected demographic variables such as (Age, Religion, Gravida, Education, 
Previous source on cord blood stem cell therapy). 
 
The review of literature was derived from primary and secondary sources along 
with professional experience and experts guidance from the field of gynecological and 
obstetrical nursing provided a comprehensive frame work for the selection of problem 
and for achieving the objectives of the study. It also strengthened the ideas for conceptual 
framework, aided to design the methodology and develop the tool for data collection. 
The conceptual framework for the study was based on king‘s goal attainment theory. 
The researcher adopted quantitative research approach and pre experimental one 
group pre test and post test only design was used to assess the effectiveness of structured 
teaching programme on knowledge and attitude regarding cord blood stem cell therapy 
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among antenatal mothers. The study was conducted among the antenatal mothers who 
attended outpatient department at Jayaa and Suguna hospital Tiruchengode, Namakkal 
district, and whoever fulfilled the inclusive criteria of the study. The sample size was 30 
who were assigned by non probability convenient sampling technique. 
 The tool for data collection had 3 parts : part - 1:Demographic data to collect 
information on Age ,Religion, Gravida, Education, Previous source on cord blood stem 
cell therapy. part - 2 : Structured knowledge questionnaire  to assess the knowledge of 
antenatal mothers regarding cord blood stem cell therapy. Part - 3: Likert Attitude 
Scale to assess the attitude of  antenatal mothers on cord blood stem cell therapy. 
 The obstetricians and gynecologist experts validated the tool the pilot study was 
conducted at Raji hospital and it was found practicable and feasible to proceed with the 
main study. The reliability  of the tool was established by test retest method for assessing 
knowledge, ‗r‘ = 0.83 and inter-rater method for assessing practice, ‗r‘=0.87.The finding 
showed that the tool was found to be highly reliable to proceed with the main study. 
 The ethical aspect of research was maintained through the study by obtaining 
ethical clearance, formal permission from the respective authorities and consent from the 
antenatal mothers. Privacy and confidentiality was maintained throughout the data 
collection period and collected data was used only for the research purpose. 
 The main study was conducted during February 2016.The collected data was 
analyzed using SPSS Version 21. 
Major findings of the study 
 The data collected was analyzed using descriptive and inferential statistics. 
Interpretation and discussion was done based on the objectives of the study, null 
hypothesis, conceptual framework and research studies from literature review. 
 In pretest Majority 30(100%) had inadequate knowledge whereas in the post 
test after imparting structured teaching programme majority 23(76.67%) had 
adequate knowledge and only 7(23.33%) had moderately  
 53 
 
adequate knowledge regarding cord blood stem cell therapy among 
antenatal mothers. 
 
 The finding also revealed that in the pretest, almost all 25(83.33%) had 
unfavourable attitude and 5(16.67%) had moderately favourable attitude 
whereas in the post test after imparting structured teaching programme 
majority 21(70%) had favourable attitude, 6(20%) had moderately favourable 
attitude and 3(10%) had unfavourable attitude regarding cord blood stem cell 
therapy among antenatal mothers. 
 The comparison tables showed  that in the pretest, the mean score of 
knowledge was 11.50 with S.D 2.70 whereas in the post test the mean score of 
knowledge was 33.06 with S.D 3.93. The calculated paired ‗t‘ value of t = 
57.742 was found to statistically significant at p<0.001 level. This clearly 
shows that the structured teaching programme imparted to antenatal mothers 
had significant improvement in the post test level of knowledge regarding 
cord blood stem cell therapy. 
 The finding also shows that in the pretest, the mean score of knowledge was 
11.50 with S.D 2.70 whereas in the post test the mean score of knowledge was 
33.06 with S.D 3.93. The calculated paired ‗t‘ value of t = 57.742 was found 
to statistically significant at p<0.001 level. This clearly shows that the 
structured teaching programme imparted to antenatal mothers had significant 
improvement in the post test level of knowledge regarding cord blood stem 
cell therapy. 
 The relationship between that the post mean score of knowledge was 33.06 
with S.D 3.93 and the post test attitude score was 78.40 with S.D 14.31. The 
calculated Karl Pearson‘s Correlation value of r = 0.715 shows a positive 
correlation and it was found to be statistically significant at p<0.01 level. This 
clearly indicates that when the knowledge regarding cord blood stem cell 
therapy among antenatal mothers increases their attitude level also increases. 
 
 54 
 
CONCLUSION 
 The present study assessed the effectiveness of structured teaching programme on 
knowledge and attitude regarding cord blood stem cell therapy among antenatal mothers. 
The results revealed that structured teaching programme is very effective in increasing 
the level of knowledge and attitude at p<0.01 level. From the findings of the study, the 
investigator concluded that structured teaching programme has an important role in 
increasing level of knowledge and attitude regarding cord blood stem cell therapy among 
antenatal mothers. 
IMPLICATIONS 
 The implications drawn from this study are of importance to the field of nursing 
including nursing service, administration, education and research. 
Nursing Practice 
 The nurse as a service provider should periodically organize and conduct mass 
education programme on cord blood stem cell therapy among antenatal 
mothers. 
 The nurse implements the information, education, communication to create 
aware to the antenatal mothers about stem cell therapy. 
  As a service provider the nurse should implement cord blood stem cell 
therapy among antenatal mothers and improve their knowledge. 
Nursing Education 
 Nurses must be reinforced in-service education regarding define stem cell 
therapy and it‘s types, disease treated by umbilical cord, procedure to collect 
stem cells. 
 Nursing students have to be educated regarding cord blood stem cells therapy 
among antenatal mothers. 
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 Nurse educators should emphasize the proper education about stem cell 
therapy as well as provide opportunity for students to apply the knowledge in 
their practice. 
Nursing Administration 
 The nurse as an administrator should implement formal teaching programme 
on cord blood stem cell therapy among antenatal mothers. 
 Provide opportunities for nurses to attend training programmes. 
 The nurse must instrumental in pointing out relevant policies of the state and 
central level of ensure effective programme to educate the public and facilitate 
optimal recourses allocation for implementation of the programme and create 
intersectional network about cord blood stem cell therapy. 
Nursing Research 
 Nurse researchers can promote more research with regard to utilization of 
disease treated by cord blood stem cell therapy. 
  Nurse researchers can collaborate with the other health team members in 
developing evidence based nursing practice. 
 Nursing researcher can encourage clinical nurse to apply the research findings 
in their daily nursing care activities. 
RECOMMENDATIONS 
 Nursing research is a widely expanding area with need for validating 
conservative, interventions and development of new knowledge. This study recommends 
the following for achieving this end. 
 A comparative study can be carried out to assess the factors leading to the 
development of cord blood stem cell therapy between rural and urban 
population. 
 A video teaching program on cord blood stem cell therapy can be conducted 
in larger samples for better generalization. 
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 A comparative study can be conducted to compare the effect of  structured 
teaching programme among experimental group and control group without 
intervention. 
LIMITATIONS 
 The study was confined to small number of subjects and shorter period. 
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APPENDIX I 
LETTER SEEKING PERMISSION TO CONDUCT STUDY 
 
From 
 Mrs. S.Gomathi,  
II year M.Sc (N), 
Arvind College Of Nursing 
Namakkal. 
Forwarded Through 
Prof. Mrs. V. Kavitha M.Sc (N)  
Principal, 
Arvinth College of Nursing, 
Namakkal. 
To 
 The Administrator 
 Jayaa and Suguna Hospitals, 
   Tiruchengode, 
 Namakkal 
Respected Madam/Sir, 
        Subject : Requesting permission to conduct research in the hospital 
 As a part of  M.Sc Nursing requirement under the fulfillment of the Tamilnadu 
Dr. M.G.R University,I am conducting a research on ―A study to assess the 
effectiveness of structured teaching programme on knowledge and attitude 
regarding cord blood stem cell therapy among antenatal  mothers in selected private 
hospitals at Namakkal district”.Kindly grant me permission to conduct research in your 
esteemed hospital. 
Thanking you, 
         Yours faithfully 
            (S.Gomathi) 
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APPENDIX II 
LETTER SEEKING EXPERTS OPENION FOR CONTENT VALIDITY 
 
From 
 Mrs. S.Gomathi,  
II year M.Sc (N), 
Namakkal. 
To 
 
 
Respected Madam/Sir, 
 Sub: requisition for expert opinion on suggestion for content validity of the tool. 
I am Mrs. S.Gomathi doing my M.Sc Nursing II year specializing in obstetrical 
and gynaecological nursing at Arvinth college of Nursing. As a part of my research 
project to be submitted to the Tamilnadu Dr. M.G.R University requirement for the award 
of M.Sc (N) degree, I am conducting ―A study to assess the effectiveness of structured 
teaching programme on knowledge and attitude regarding cord blood stem cell 
therapy among antenatal mothers in selected private hospitals at Namakkal 
district”. 
I have enclosed my data collection tool and intervention tool for your expert 
guidance and validation. Kindly do the needful. 
Thanking you, 
         Yours faithfully 
            (S.Gomathi) 
Enclosures: 
 1. Research Proposal 
 2. Data collection tool 
 3. Intervention tool 
 4. Content validity form 
 5. Certificate for content validity 
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APPENDIX III 
LIST OF EXPERTS FOR CONTENT VALIDITY 
 
 
1. Mrs.Malathi, M.Sc (Nursing) 
      Associate Professor, 
      J.K.K Nataraja College of nursing, 
      Komarapalayam. 
 
2. Mr.A.Hamidhunniza, M.Sc (Nursing) 
     Associate Professor, 
     Nandha College of nursing, 
     Erode. 
 
3. Mrs. S.Menaka, M.Sc (Nursing), 
    Annai J.K.K Sampoorani ammal College of nursing, 
    Komarapalayam. 
 
4. Dr. Mrs.G.Manimekalai, 
     Jayaa Hospital,  
     Tiruchengode. 
 
5. Dr. Mrs.S.Rajeswari, 
     Raji Hospital,  
     Tiruchengode. 
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APPENDIX IV 
FORMAT FOR CONTENT VALIDITY 
Name of the Expert : 
Address  : 
Total content of the tool: Adequate / Inadequate 
Kindly Validate each tool and tick if it applicable 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
              Signature of the expert with date 
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CRITERIA CHECK LIST FOR VALIDATION OF TOOL 
 
Instruction 
 Kindly go through the items regarding accuracy, relevancy and appropriateness of 
the content. There are two response columns in the checklist namely agree, and disagree. 
Place a tick mark against the specific column. If you disagree, to any of the item, write 
your remarks and suggestion in given column. 
 
PART - I 
DEMOGRAPHIC PERFORMA 
 
 S.No 
 
 
          Agree 
 
         Disagree 
 
          Remarks And Suggestions 
1    
2    
3    
4    
5    
6    
7    
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PART -II 
STRUCTURED KNOWLEDGE QUESTIONNAIRE REGARDING CORD 
BLOOD STEM CELL THERAPHY AMOUNG ANTENATAL MOTHERS. 
 
S.No 
 
     Agree 
 
     Disagree 
 
              Remarks and suggestions 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
13    
14    
15    
16    
17    
18    
19    
20    
21    
 68 
 
22    
23    
24    
25    
26    
27    
28    
29    
30    
31    
32    
33    
34    
35    
36    
37    
38    
39    
40    
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SCORE KEY FOR STRUCTURED KNOWLEDGE QUESTIONNAIRE 
        QUESTION NO                  ANSWER                     SCORE 
1 a 1 
2 b 1 
3 a 1 
4 c 1 
5 a 1 
6 a 1 
7 a 1 
8 a 1 
9 a 1 
10 a 1 
11 d 1 
12 b 1 
13 b 1 
14 b 1 
15 a 1 
16 c 1 
17 c 1 
18 b 1 
19 d 1 
20 c 1 
21 c 1 
22 b 1 
23 c 1 
24 b 1 
25 d 1 
26 a 1 
27 a 1 
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28 c 1 
29 c 1 
30 d 1 
31 c 1 
32 b 1 
33 d 1 
34 d 1 
35 a 1 
36 a 1 
37 a 1 
38 a 1 
39 a 1 
40 d 1 
 
       SCORE: 40 
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PART - III 
LIKERT ATTITUDE SCALE REGARDING CORD BLOOD STEM CELL 
THERAPY AMONG ANTENATAL MOTHERS 
S.No Question Strongly 
agree 
 
(5) 
Agree 
 
 
(4) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(2) 
Strongly 
Disagree 
 
(1) 
1 1      
2 2      
3 3      
4 4      
5 5      
6 6      
7 7      
8 8      
9 9      
10 10      
11 11      
12 12      
13 13      
14 14      
15 15      
16 16      
17 17      
18 18      
19 19      
20 20      
NOTE: 
 This is for positive statements. It will be reversible for negative statements. 
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APPENDIX V 
INFORMED CONSENT FORM 
  
I am Mrs. S.Gomathi doing my M.Sc Nursing II year student at Arvinth college of 
Nursing, Namakkal, as a part of my research study on ―A study to assess the 
effectiveness of structured teaching programme on knowledge and attitude 
regarding cord blood stem cell therapy among antenatal mothers in selected private 
hospitals at Namakkal district”, is selected to be conducted. The findings of the study 
will be helpful in gaining knowledge on prevention of coronary artery disease. 
I hereby ask you consent and cooperation to participate in the study. The 
information collected will be confidently and anonymity will be maintained. 
 
 
         
          (Signature of investigator) 
 
I__________________________________, here by consent to participate and 
undergo the study. 
 
Place: 
Date: 
 
 
 
 
(Signature of the participant) 
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APPENDIX VI 
CERTIFICATE FOR CONTENT VALIDITY 
 
 This is to certify that the tool developed by S.Gomathi, M.Sc Nursing II year 
student at Arvinth college of Nursing for his study, ―A study to assess the effectiveness 
of structured teaching programme on knowledge and attitude regarding cord blood 
stem cell therapy among antenatal mothers in selected private hospitals at 
Namakkal district”, is validated by the undersigned and he can proceed with this tool to 
conduct the main study. 
 
 
 
 
Seal: 
Signature with Date 
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APPENDIX VII 
CERTIFICATE OF ENGLISH EDITING 
 
TO WHOM SO EVER MAY CONCERN 
 
 This is to certify the dissertation work ―A study to assess the effectiveness of 
structured teaching programme on knowledge and attitude regarding cord blood 
stem cell therapy among antenatal mothers in selected private hospitals at 
Namakkal district”, done by S.Gomathi, II year M.Sc Nursing student at Arvinth 
college of Nursing, Namakkal, is edited for English language appropriateness. 
 
 
 
 
 
Seal with Date: 
Signature 
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APPENDIX VIII 
CERTIFICATE OF TAMIL EDITING 
 
TO WHOM SO EVER MAY CONCERN 
 
 This is to certify the dissertation work ―A study to assess the effectiveness of 
structured teaching programme on knowledge and attitude regarding cord blood 
stem cell therapy among antenatal mothers in selected private hospitals at 
Namakkal district”, done by S.Gomathi, II year M.Sc Nursing student at Arvinth 
college of Nursing, Namakkal, is edited for tamil language appropriateness. 
 
 
 
 
 
Seal with Date: 
Signature 
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LESSON PLAN 
ON 
STEM CELL THERAPY 
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LESSON PLAN 
 
Name of the topic         : Stem Cell Therapy 
Duration                        : 1hour 
Group and Number       : Antenatal mothers, 30 
Place                              :Selected hospitals at Namakkal district 
Method of teaching       : Lecture cum discussion 
Medium of Instruction  : Tamil 
Teaching Aid                 : Power point presentation 
Health Educator            :  Student Teacher 
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GENERAL OBJECTIVE 
 
                      The antenatal mother will be able to gain adequate knowledge and improve attitude about stem cell therapy and  can improve the baby health. 
 
 
SPECIFIC OBJECTIVE 
 
                       The antenatal mothers will be able to, 
 
 Introduce the topic 
 Define normal cell structure. 
 Describe normal cell division. 
 Define stem cells. 
 State history of Stem Cell Therapy. 
 List down types of stem cells. 
 Describe the properties of stem cells. 
 Enumerate diseases treated by umbilical cord blood. 
 Explain procedure to collect stem cells. 
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S.NO TIME 
 
SPECIFIC 
OBJECTIVE 
 
CONTENT 
 
TEACHER‟S 
&  
LEARNER‟S  
ACTIVITY 
Av.Aids 
 
EVALUATION 
 
 
1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 mts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduce the 
topic 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Every baby deserves the right to start  healthy life‖ 
 
The umbilical cord is one of the richest source of pure 
young stem cells in the human body.Stem cells are the 
very foundation of the human body.Every part of our 
body including blood,bone,skin and muscles are formed 
from master cells known as stem cells.Cord blood stem 
cells are master cells of our body used in the treatment of 
nearly 80 diseases,including wide range of cancers,genetic 
diseases and blood transplant. When a transplant is 
successful a healthy new immune system has been 
treated.Umblical cord stem cells when preserve under 
cryogenic conditions have no expiration date, thereby 
providing life time benefit. 
 
Explaining 
topic with 
help of  the 
powerpoint 
Presentation 
 
 
 
 
 
 
 
 
powerpoint 
Presentation 
 
 
 
 
 
 
 
 
 
 
 
What is stem 
cell therapy? 
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2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 mts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Define normal 
Cell Structure  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Cells the basic form of life.Every organ is composed of 
cells As soon as the fertilization is completed, cells start to 
divide into millions of cells to form the shape of the 
organism. There are two major types of cells that are 
present . They are stem cells and normal cells .  
Normal cells are the cells that have been 
differentiated to perform a special function in a localized 
area in the body. Human body contains about 40 trillion 
cells and almost all of them are normal cells. Stem cells 
can make copies of  itself  and  make  more specialized 
type of cell .     
 
Explain about 
the normal 
cells with help 
of AV.aids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
powerpoint 
Presentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What are the 
normal cell 
membrane ? 
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  A cell consists of anucleus and cytoplasm and is 
contained within the cell membrane , which regulates 
Questioning 
and answering 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Power point 
presentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What  are the 
different cells? 
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What passes in and out.The nucleus contains 
chromosomes,which are the cell‘s genetic material and a 
nucleus which produces ribosomes. Ribosomes produce 
proteins, which are packaged by the golgi apparatusso that 
they can leave the cell. The cytoplasm consists of a fluid 
material and organelles,which could be considered the 
cell‘s organs.The endoplasmic reticulum transports 
materials within the cell.Mitochondria generate energy for 
the cell‘s activities.Lysosomes contain enzymes that can 
break down particles entering the cell. 
 
 
 
 
 
Questioning 
and answering 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Power point 
presentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What are the 
normal cell 
membrane ? 
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3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 mts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Describe 
normal cell 
division 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal cell devision  
Depending on the type of cell, there are two ways cells 
divide—mitosis and meiosis. Each of these methods of 
cell division has special characteristics. One of the key 
differences in mitosis is a single cell divides into two cells 
that are replicas of each other and have the same number 
of chromosomes. This type of cell division is good for 
basic growth of  Somatic cells make up most of your 
body's tissues and organs, including skin, muscles, lungs, 
gut, and hair cells repair and maintenance. In meiosis a 
cell divides into two cells that have half the number of 
chromosomes. Reducing the number of chromosomes by 
half is important for sexual reproduction and provides for 
genetic diversity. 
 
 
 
Explain about 
the normal 
cell division 
with the help 
of Av .aids 
 
 
 
 
 
 
 
 
 
 
 
 
 
Listening and 
asking doubts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What is normal 
cell division? 
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4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 mts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Define stem 
cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEFINE STEM CELLS 
Stem cells are the cells that can develop into other types 
of cells, especially during the embryonic period. They are 
actually undifferentiated typical cells. During the 
development of an animal, these cells will divide by 
 mitosis to produce differentiated cells such as white 
blood cells, red blood cells, neurons, etc. Two categories 
of stem cells can be found in our bodies. Stem cells found 
inside the blastocyst during the embryonic period are 
known as embryonic stem cells. stem cells are infused 
into a patient‘s blood stream where they go to work 
healing and reparing damaged cell and tissue. The other 
type is called adult stem cells.The british law which 
regulates the storage and use of embryos called human 
embryo protection act. 
 
 
 
Explaining 
the content 
with the help 
of Av.aid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Power point 
presentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What are all 
the different 
types of stem 
cells? 
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5 
 
 
 
 
 
 
 
7 mts 
 
 
 
 
 
State history of 
stem cell 
therapy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HISTORY OF STEM CELL THERAPY 
                 Stem cells have an interesting history that has 
been somewhat tainted with debate and controversy. In 
the mid 1800s it was discovered that cells were basically 
the building blocks of life and that some cells had the 
ability to produce other cells. Attempts were made to 
fertilise mammalian eggs outside of the human body and 
in the early 1900s, it was discovered that some cells had 
the ability to generate blood cells. 
 1974 – First reports on the presence of stem 
/progenitor cells in human cord blood. 
 1983 – Dr.Hal Broxmeyer and Colleagues are the first 
to propose the concept of using umbilical cord blood 
as an alternative source of stem cells to bone marrow 
for transplant.They created the first ―proof of 
principle‖ for cord blood bank. 
 1988-Dr.Eliane Gluckman of St.Louis hospital paris- 
the first successful cord blood transplant in the world 
Questioning 
and answering 
 
   
 
 
 
 
 
 
 
Power point 
presentation 
 
 
 
 
 
 
 
 
 
 
 
What is the 
history about 
stem cells? 
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is preferred in france on 5 year old boy ,(Matthew 
Farrow)suffering from ―fanconi‘s‖ anemia (blood 
disorder).cord blood collected from his sister birth and 
stored by  Dr.Hal Broxmeyer. 
 1990 – World‘s  first cord blood transplant for the 
treatment of leukemia is performed by Dr.John 
Wagner at the university of Minnesota. 
 1993-World‘s first unrealated cord blood transplant is 
performed by Dr.Kurtzberg at Duke university 
medical center. 
 2004- Illinois becomes first state to enact legislation 
supportive of cord blood banking. 
 2004 -05 – Researchers confirm that pluripotent stem 
cells are present in cord blood.This indicating the 
possible use of cord blood for the treatment of 
diseases other than those of blood origin. 
 2008-12,000 cord blood stem cell transplants have 
been performed worldwide.Cord blood is being used 
in the treatment of 80  life –threatening diseases. 
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6 7 mts 
 
List down types 
of stem cells 
 
TYPES OF STEM CELLS 
 Stem cells are the foundation for every organ and 
tissue in your body. There are many different types of 
stem cells that come from different places in the body or 
are formed at different times in our lives. 
 
 These include 
 Embryonic stem cells 
 Tissue-specific stem cells 
 Mesenchymal stem cells 
 Induced pluripotent stem cells 
 
 
Embryonic stem cells 
Embryonic stem cells are obtained from the inner 
cell mass of the blastocyst, a mainly hollow ball of cells 
that, in the human, forms three to five days after an egg 
cell is fertilized by a sperm.  
Explaining 
the content 
with the help 
of Av.aid 
 
Power point 
presentation 
 
What are all 
the different 
types of stem 
cells? 
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In normal development, the cells inside the inner cell 
mass will give rise to the more specialized cells that give 
rise to the entire body—all of our tissues and organs. 
However, when scientists extract the inner cell mass and 
grow these cells in special laboratory conditions, they 
retain the properties of embryonic stem cells.  
Embryonic stem cells are pluripotent, meaning they can 
give rise to every cell type in the fully formed body, but 
not the placenta and umbilical cord. In the year of 1998 
human embryonic stem cells first successfully produced 
and cultured. Invitro fertilization are the blastocyst used to 
make human  embryonic stem cells about 4-5 
days.Embryonic stem cells for treating such immune 
disorders as type 1 diabetes and rheumatoid arthritis. 
 
Tissue-specific stem cells 
Tissue-specific stem cells (also referred to 
 89 
 
as somatic or adult stem cells) are more specialized than 
embryonic stem cells. Typically, these stem cells can 
generate different cell types for the specific tissue or 
organ in which they live. 
For example, blood-forming (or hematopoietic) stem cells 
in the bone marrow can give rise to red blood cells, white 
blood cells and platelets. 
 
Tissue-specific stem cells can be difficult to find in the 
human body, and they don‘t seem to self-renew in culture 
as easily as embryonic stem cells do.  
Mesenchymal Stem Cells 
These are multipotent stem cells normally found in 
the bone marrow and are derived from mesenchyme. They 
differentiate into adipocytes, chondrocytes, osteoblasts, 
myocytes and tendon. MSCs can also be extracted from 
blood, fallopian tube, fetal liver and lungs. 
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Induced pluripotent stem cells 
Induced pluripotent stem (iPS) cells are cells that 
have been engineered in the lab by converting tissue-
specific cells, such as skin cells, into cells that behave like 
embryonic stem cells. IPS cells are critical tools to help 
scientists learn more about normal development and 
disease onset and progression, and they are also useful for 
developing and testing new drugs and 
therapies.Pluripotent stem cells are  now defined as those 
able to make all cells except extra embryonic  tissues such 
as placenta. 
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7. 
 
 
6 mts 
 
Describe the  
properties of 
stem cells 
 
 
PROPERTIES OF STEM CELLS 
 
 
 
Stem cells differ from other kinds of cells in the body. All 
stem cells—regardless of their source—have three general 
properties: 
 
 they are capable of dividing and renewing    
 
Explaining 
the content 
with the help 
of Av.aid 
 
Power point 
presentation 
 
What are the 
Properties of 
stem cells? 
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themselves for longer periods 
 they are unspecialized  
  they can give rise to specialized cell types. 
small volume of liquid corresponds to 470 million Total 
Nucleated Cells (TNC) or 1.8 million cells that test 
positive for the stem cell marker CD34.  Thus, most 
healthy full-term babies have over a million blood-
forming stem cells in their umbilical cord blood.    
 
 
8. 
11 mts Enumerate 
diseases treated 
by umbilical 
cord blood. 
 
 
DISEASES TREATED BY UMBILICAL CORD 
BLOOD STEM CELLS 
         Since 1989, umbilical cord blood has been used 
successfully to treat children with leukaemia, anaemias 
and other blood diseases. Researchers are now looking at 
ways of increasing the number of haematopoietic stem 
cells that can be obtained from cord blood, so that they 
can be used to treat adults routinely too.Leukaemia 
patients must receiving stem cells transplants from closely 
related doners such as sibilings. 
 
Explaining 
the content 
with the help 
of Av.aid 
 
Power point 
presentation 
 
How to treat 
disease by  
umbilical cord 
blood? 
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 Leukemias, Lymphomas and other Blood Cancers 
Acute Biphenotypic Leukemia 
Acute Lymphocytic Leukemia (ALL) 
Acute Myelogenous Leukemia (AML) 
Acute Undifferentiated Leukemia 
Adult T Cell Leukemia/Lymphoma 
Chronic Lymphocytic Leukemia (CLL) 
Chronic Myelogenous Leukemia (CML) 
Hodgkin‘s Lymphoma 
Juvenile Chronic Myelogenous Leukemia (JCML) 
Juvenile Myelomonocytic Leukemia (JMML) 
Multiple Myeloma 
Myeloid/Natural Killer Cell Precursor Leukemia 
Non-Hodgkin‘s Lymphoma 
Prolymphocytic Leukemia 
Plasma Cell Leukemia 
Waldenstrom‘s Macroglobulinemia and so.  
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9. 10 mts Explain 
Procedure to 
collect stem cell 
 
PROCEDURE TO COLLECT STEM CELLS 
 Umbilical cord blood bank collection centers 
are  in various places of India , like Chennai 
,Mumbai, Newdelhi, Pune, Kolkata, 
Hyderabad ,Bangalore, Ahmedabad and 
various other cities . 
Current Cost of Cord blood stem cell 
Therapy 
  
ANNUAL 
STORAGE 
 
21 YRS 
 
LIFE TIME 
 
processing 
fee 
 
10,000 
 
10,000 
 
10,000 
 
storage 
fee 
 
3,500/ 
monthly 
 
25,000 
(single 
payment) 
 
40,000 (single 
payment 
 
Explaining 
the content 
with the help 
of Av.aid 
Power point 
presentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How much 
blood collected 
from the baby? 
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 The science of cryobiology tells us that cells 
which are cryogenically preserved remain 
viable for decades.  It has been confirmed 
that cord blood stem cells were still viable 
after being frozen 23+ years. 
 The median size of cord blood collections in 
family banks is 60mL or 2 ounces.   
 The hospital should intimate to the service 
centre regarding placental stem cells 
collection between 1-6 months of pregnancy. 
 The antenatal mother decides at the last 
moment to order a collection of cord blood 
stem cells at short notice. 
 Getting consent from the donor.  
 Explaining the procedure to the mother. 
 The mother may have a vaginal birth or a 
Power point 
presentation 
 
How to collect 
the stem cells? 
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cesarean section,the process of collecting 
new born baby‘s stem cell is safe,painless, 
and non - disruptive to mother and baby. 
 After baby is born, baby‘s umbilical cord  is 
clamped and cut. 
 A specialized blood bag is then bar-coded 
for collection of cord blood . 
 For the collection step the needle of the 
blood bag is inserted into the umbilical vein 
and  the bag is held at a lower level in order 
to allow the blood to drain into the bag .  
 Stem cells are then harvested from the cord 
blood and stored in cryo-vials at 196
0 
 c  in 
liquid nitrogen . 
 The blood volume of term baby is about 
70ml/kg while the placenta contains 45ml of 
blood per kg of fetal weight .  
 Then it is transferred to the 
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approved,heparin-free collection bags which 
are sterile. 
 To collect cord tissue the umbilical cord is 
cleaned, a small segment is placed into the 
provided collection jar,and it is sent back to 
lab with the cord blood bag. As soon as kit 
arrives to the delivery room with in 10 
minutes they are collecting blood. 
 Umbilical cord blood is collected after 
delivery of the baby from the residual blood 
in placental cord unit. 
 Once collection is done,obstetrician or 
midwife will seal the bag,attach the pre-
printed lables with mother and baby‘s 
complete  detailed information,and place it 
in the cordlife collection kit. 
 By comparison, most public cord blood 
banks will only keep collections that are 
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much bigger than average, and throw out the 
donations that are below a threshold of a 
billion TNC, corresponding to a blood 
volume of about 90-100 mL or 3 ounces. 
 The standard procedure for transporting 
fresh cord blood is to keep it within an 
ambient temperature range of 15 °C (59 
°F) to 25 °C (77 °F). 
 Public cord blood banks set a limit of 48 
hours on the time between birth and 
processing the blood for cryogenic storage.  
  In the cryopreservation process, the stem 
cells collected from umbilical cord blood  
samples,are frozen to sub zero 
temperatures(Preserved safely under-196
0 
c). 
 Umblical cord stem cells preserved under 
cryogenic conditions have no expiration date 
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there by providing life time benefit. 
 The parents, until the child become major 
remains as legal authority for placental stem 
cells utilization. 
 Proper maintenance of records. 
 Confidentiality will be maintained. 
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SUMMARY  
 So far we had seen about what is cell, stem cell and their types, sources of stem cell, how to store stem cell, stem cells banking, what are 
all the advantages and disadvantages, side effects and nurses role in stem cell therapy.   
CONCLUSION 
 From this lesson plan I learnt about stem cell therapy in detail and about stem cell banking. I hope this is very useful for me and my 
carrier. In current and future perspective of the stem cells research report, the stem cells have many significant advantages .  
 
SUMMATIVE EVALUATION 
1. What is stem cell therapy? 
2. What are all the types of stem cells? 
3. How to store the stem cell therapy 
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ÏÚjRÔ £¡fûN  
Tt±V TôP§hPm 
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TôP§hPm 
 
RûXl©u ùTVo    : ÏÚjRÔ £¡fûN 
LôXm     : 1 U¦ úSWm 
ÏÝ Utßm Gi¦dûL  : Lol©¦ RônUôoLs, 30 
CPm      : ஜெயா மற்றும் சுகுணா மருத்துவமனை,திருச்ஜெங்க ாடு 
Lt©jRp Øû\    : ®¬ÜûW Utßm LXkÕûWVôÓRp 
Lt©dÏm ùUô¯    : Rªr 
Lt©dL ERÜm ETLWQeLs : ªuLhP ®[dL Lôh£ 
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ùTôÕúSôdLm : 
  Lol©¦ RônUôoLs úTôÕUô] A±Ü ùT\ Utßm ÏÚjRÔ £¡fûN Tt±V AÔÏØû\ úUmTÓjR Ø¥Ùm 
Utßm ÏZkûR«u EPp SXjûR úUmTÓjR Ø¥Ùm. 
Ï±l©hP úSôdLeLs : 
  Lol©¦ RônUôoLs ...................... 
 RûXlûT Tt±V A±ØLm 
 NôRôWQ ùNp AûUlûT Tt± YûWVû\ 
 NôRôWQ ùNp ©¬ÜûY ®Y¬ÙeLs 
 ÏÚjRÔ YûWVû\ 
 ÏÚjRÔ £¡fûN«u YWXôß 
 ÏÚjRÔ YûLLû[ Th¥V-Ó 
 ÏÚjRÔ®u Ti×Lû[ ®Y¬jRp 
 ùRôl×sùLô¥ CWjRj§u êXm £¡fûN úSônLû[ LQd¡ÓRp 
 ÏÚjRÔdLû[ úNL¬dÏm SûPØû\Lû[ ®[dÏRp 
 RônUôoLû[ RVôoTÓjR Utßm TWôU¬l©p ùN®-V¬u ùTôßl×Ls 
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Y. 
Gi 
úSWm 
Ï±l©hP 
úSôdLm 
ùTôÚPdLm 
BnYô[o 
ùNVp 
LtúTô¬u 
ùNVp 
J° 
Utßm 
J- 
AûUl× 
U§l©ÓRp 
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
¨ªPe
Ls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RûXl× 
A±ØLm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ØuàûW : 
 ―JqùYôÚ ÏZkûRÙm BúWôd¡VUô] YôrdûL 
ùRôPeL N¬Vô] RÏ§Vô]Yo‖ 
    ùRôl×sùLô¥ U²R EP-p A§LT¥Vô] çV 
C[m ÏÚjRÔdLs Es[Õ. EP-u JqùYôÚ 
Eßl×Ls ARôYÕ CWjRm, GÛm×, úRôp Utßm 
NûR CûûYLs Aû]jÕm UôvPo ùNpL[ôp 
EÚYôdLlTÓ¡u\] ARôYÕ ÏÚjRÔdLs 
¡hPjRhP 80 YûLVô] úSônLû[ ÏQlTÓj 
Õ¡u\]. ARôYÕ ×tßúSônLs, UWTÔ úSônLs 
Utßm CWjR Uôtß ùRôl×sùLô¥ CWjR Uôtß 
ÏÚjRÔdLs Eh×Ïj§ úSôVô°«u ÏÚ§úVôhPm 
GeùLpXôm úYûX ùNnÕ úNRUûPkR ùNpLs 
Utßm §ÑdLû[ ÏQUûP¡u\]. GlùTôÝÕ 
BúWôd¡VUô] G§ol×Nd§ Uôt\lThÓ ÏQlTÓj 
RlTÓ¡u\]. ùRôl×sùLô¥ ÏÚjRÔdLs ªL 
Ïû\kR ùYlT¨ûX«p TôÕLôdLlThÓ YÚ¡u\]. 
LôXôY§ úR§ CpXôR YôrdûL Øû\dÏ SuûU 
TVd¡u\]. 
 
 
®[dÏRp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LY²jRp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ªuLhP 
®[dL 
Lôh£ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ÏÚjRÔ 
£¡fûN 
Gu\ôp 
Gu]? 
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2 7 
¨ªP 
eLs 
 
 
 
NôRôWQ 
ùNp 
AûUlûT 
Tt± 
YûWVû\ 
 
ùNpLs E«¬u A¥lTûP YôrdûL ®ûW®p 
LÚjR¬jRp Ø¥kRÜPu E«WÔdLs E«¬]jûR  
Y¥®p AûUdL ùNpLs ªp-Vu LQd¡p ©¬dL 
ùRôPeÏm. ùNpLs Ød¡VUôL CWiÓ YûLLs 
Es[]. ARôYÕ ÏÚjRÔ Utßm NôRôWQ 
ùNpLs. 
NôRôWQ ùNpLs EP-u úYßThP TÏ§«p JÚ 
£\l× ùNpTôÓLû[ ùLôiÓs[]. U²R EP-p 
40 ¥¬p-Vu ùNpLs Es[PeÏm Utßm 
¡hPjRhP Aû]jÕm NôRôWQ ùNpLL[ôL 
Es[]. JqùYôÚ Eßl×m ùNpL[ôp 
EÚYô¡u\]. CÚl©àm EPp LhPûUl× Utßm 
Ti×Ls JqùYôÚ Eßl©-ÚkÕm úYßThÓ 
LôQlTÓ¡u\]. NôRôWQ ùNpLs Ut\ YûLVô] 
ùNpL°-ÚkÕ úYßTÓj§ LôhÓm §\u CpûX. 
B]ôp AûYL°p ùTÚmTôÛm CûZÙÚl©¬Yôp 
©¬dLØ¥Ùm. AúR úSWj§p ùNpLs CûZÙßl©¬Ü 
CÚlTûR AàU§lT§pûX. 
®[dÏRp 
 
 
LY²jRp 
 
ªu LhP 
®[dL 
Lôh£   
 
ùNp ©¬Ü 
Gu\ôp 
Gu]? 
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    ùNpLs LÚ Utßm LXÜ«¬]ôp 
BdLlTÓ¡u\]. CûYLs ùNpúRôÛPu 
CûQdLlThÓs[]. EhLÚ ÏúWôúUôúNômLs, 
UWTÔdLs, Utßm ÖiLÚdLû[ 
ùLôi¥Úd¡u\]. CûYLs ¬úTôúNômLû[ 
EÚYô¡u\]. ¬úTôúNômLs ×WReLû[ 
EÚYô¡u\].  
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    úLôpûLAlTWPv ùNpLû[ ®hÓ Es[]. 
ûNhúPô©[ôNm §WY ùTôÚs Utßm EsÞßl×Lû[ 
ùLôiÓs[Õ. CûYLs ùNpEßl×Ls Guß 
LÚRlTÓ¡u\]. GiúPô©[ôªd ùWh¥Ï[m 
êXlùTôÚsLû[ ùNpÛÏs ùLôiÓ ùNp¡u\]. 
ûUhúPôLôi¥¬Vô RûXØû\ ùNpLû[ CVdL 
FdÏ®d¡u\]. ûXúNôúNômLs ùNp ÖûZÙm 
ÕLsLû[ EûPdL Ø¥VôR GuûNmLû[ 
ùLôi¥Úd¡u\]. ÕûQLÚU¦ ùNp©¬®p 
TeúLt¡u\].  
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3 
 
3 
¨ªPe
Ls 
 
NôRôWQ 
ùNp 
பிரிதல் 
பற்றி 
®Y¬ 
ÙeLs. 
 
 
NôRôWQ ùNpL°u YûLTôÓ : 
  ùNpLs CWiÓ YûLL[ôL ©¬dLlTÓ¡u\]. 
AûY CûZÙÚl©¬Ü Utßm JÓdLt©¬Ü. CkR 
YûLVô] ùNpLs JqùYôußm £\l× Ti×Lû[ 
ùLôiÓs[]. CûZÙÚl©¬®u Ød¡V úYßTôÓ  
Jtû\ ÏÚjRÔdLû[ ùLôiÓs[].  
 
      CÕ CWiPôL ©¬ÙmùTôÝÕ JjR 
ÏúWôúUôúNômLû[ ùLôi¥«Úd¡u\]. CkR 
YûLVô] ùNpLs EP-u A¥lTûP Y[of£Vô] 
§Ñ, EPpEßl×Ls, úRôp RûN, ÖûWÂWp,  ÏPp 
Utßm Ø¥ CûYLLs Tô§dLlThPôp ùNpLs 
TôÕLôdL ERÜ¡u\]. JÓdLt©¬Ü ùNpLs 
CWiPôL ©¬YûPÙmùTôÝÕ ÏúWôúUôúNômL°u 
Gi¦dûL Tô§VôL Ïû\¡u\]. úUÛm Tô-Vp 
C]lùTÚdLm Utßm ÏÚjRÔdLs úYßThÓ 
LôQlTÓ¡u\]. 
 
®[dÏRp 
 
LY²jRp  
 
ªu LhP 
®[dL 
Lôh£ 
 
NôRôWQ 
ùNpLs 
Gu\ôp 
Gu]? 
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4 
 
3 
¨ªPe
Ls 
 
ÏÚjRÔ 
YûWVû\ 
 
ÏÚjRÔ YûWVû\ : 
   ÏÚjRÔdLs Ï±lTôL LÚLôXj§p, Ut\ 
YûLVô] ùNpL°-ÚkÕ EÚYô¡u\]. 
EiûU«p YZdLUô] ùNpL°-ÚkÕ úYßTôPtß 
LôQlTÓ¡u\]. ®XeÏ EÚYôôdLj§uúTôÕ 
CûZÙßl©¬®p ùNpLs CWjR ùYsû[ AÔdLs, 
CWjR £YlTÔdLs Utßm ¨ëWôuLs úTôuß 
úYßThP ùNpLLû[ EtTj§ ùNp¡u\]. SUÕ 
EPp CWiÓ YûLVô] ÏÚjRÔdLû[ 
ùLôiÓs[Õ. LÚ LôXj§p ©\l©tÏ ØkûRV 
LÚ®u Y[of£«p LôQlTÓm ÏÚjRÔdLs LÚ 
ÏÚjRÔdLs Guß AûZdLlTÓ¡u\]. 
Utù\ôuß Ø§of£VûPkR ÏÚjRÔdLs Guß 
AûZdLlTÓ¡u\]. 
 
®[dÏRp 
 
LY²jRp 
 
ªuLhP 
®[dL 
Lôh£ 
 
ÏÚjRÔ 
L°u 
úYßThP 
YûLLs 
Gu]? 
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5 
 
7 
¨ªPe
Ls 
 
ÏÚjRÔ 
£¡fûN 
«u 
YWXôß 
 
ÏÚjRÔ £¡fûN Øû\ Tt±V YWXôß : 
  ÏÚjRÔdLs Tt±V YWXôß ªL ÑYôWvVUô] 
KW[Ü ®YôRRm Utßm NofûNdÏ¬V LÚjÕ 
úYßTôÓLÞPu LôQlTÓ¡\Õ. 1800 L°p ùNpLs 
YôrdûL«u A¥lTûPûV ùLôi¥ÚkRÕ Guß 
LiÓ©¥dLlThPÕ Utßm £X ùNpLs Ut\ 
ùNpL°u EtTj§ §\²p CÚkRÕ Gußm U²R 
EP-u ùY°úV Tôíh¥ ØhûPLs Y[UôdÏ 
ØVt£Ls úUtùLôs[lThP]. 1900L°p £X 
ùNpLs CWjR AÔdLû[ EÚYôdÏm §\u 
ùLôiPRôL CÚdÏm Guß LiP±lThPÕ. 
  1974-p ØRu ØR-p U²R ùRôl×sùLô¥ CWjR 
ÏÚjRÔdLs LiÓ©¥dLThPÕ. 
   1983-p PôdPo aôp ©WôdvªVo Utßm 
ùLôúX´Vv ØRu ØR-p NL GÛm× Uwû_«p 
Es[ ÏÚjRÔdLs JÚ Uôtß BRôWUôL 
ùRôl×sùLô¥ CWjRjûR TVuTÓj§]o. CYoLs 
ùRôl×sùLô¥ WjR Ye¡ BRôW ùLôsûLûV 
EÚYôd¡]o. 
 
 
®[dÏRp 
 
LY²jRp 
 
ªu LhP 
®[dL 
Lôh£ 
 
ÏÚjRÔ 
L°u 
YWXôß 
Gu\ôp 
Gu]? 
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  1988-p PôdPo.G¯ú] ÏÚdúUu ùN«ihP 
í«v UÚjÕYUû]«p EX¡u ØRu ØR-p 
NLGÛm× Uwû_«p Es[ ÏÚjRÔdLs JÚUôtß 
BRôWUôL ùRôl×sùLô¥ CWjRjûR Tn]TÓj§]o. 
CYoLs ùRôl×sùLô¥ WjR Ye¡ 
BRôWùLôsûLûV EÚYôd¡]o. 
  1988-p PôdPo. G¯ú] ÏÛdúUu ùN«ihP 
í«v UÚjÕYUû]«p EX¡u ØRu ØRXp 
ùYt±LWUô] ùRôl×sùLô¥ CWjR Uôtß £¡fûN 
Øû\ûV 5 YVÕ £ßYàdÏ (UjúRÙTôúWô) 
ùNnVlThPÕ. CYu CWjRúNôûL (CWjRúLô[ôß) 
úSôVôp AY§Ùtß CÚkRôu. AYàûPV 
ReûL«u ùRôl×sùLô¥ CWjRjûR PôdPo.aôp 
©WôdvªVo êXm úNL¬dLlThÓ 
ÏQlTÓjRlThPÕ.  
   1990-p CWjR ×tßúSôn (ùYsû[ AàdLs) 
£¡fûNûV EX¡u ØRu ØR-p ùRôl×sùLô¥ 
CWjR Uôtß Øû\ûV ª]úNôhPô 
TpLûXdLZLj§p PôdPo._ôuYôd]o 
ùNVpTÓj§]ôo. 
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   1993-p EX¡u ØRu ØR-p ùRôl×sùLô¥ 
ApXôR CWjR Uôtß Øû\ûV ¥ëd TpLûXdLZL 
UÚjÕYûUVj§p PôdPo.TohvTod GuTYo 
ùNVpTÓj§]ôo. 
   2004-p Cp-]ônv ùRôl×sùLô¥ WjR Ye¡ 
BRWYôL NhPjûR CVt±V§p ØRp Uô¨Xm BÏm. 
   2004 - 2005p BWônf£Vô[oLs TX§\u 
ÏÚjRÔdL°u ùRôl×sùLô¥ CWjRj§p 
CÚlTRôL LiP±VlThÓs[Õ. CRuêXm CWjR 
NôokR úSônLû[ ÏQlTÓjR Ø¥Ùm Guß 
Eß§ùNnR]o. 
   2008-p EXL A[®p 12,000 úToLÞdÏ 
ÏÚjRÔdLs Uôt\lThÓs[Õ. CR]ôp CWjR 
NôokR úSônLs ÏQlTÓjRlThÓ YÚ¡u\]. 
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6 
 
7 
¨ªPe
Ls 
 
ÏÚjRÔ 
YûLLû[ 
Th¥V-ÓL 
 
ÏÚjRÔdL°u YûLLs : 
  ÏÚjRÔdLs EP-p Es[ JqùYôÚ Eßl× 
Utßm §ÑdL°Ûm Es[]. EP-u TpúYß 
CPeL°p CÚkÕm ApXÕ Sm Yôr®p ùYqúYß 
úSWeL°Ûm ÏÚjRÔdLs EÚYô¡u\]. 
ÏÚjRÔdL°u TpúYß YûLLs : 
 LÚ ÏÚjRÔdLs 
 §Ñ Ï±l©hP ÏÚjRÔdLs 
 CûPÖûZj§Ñ ÏÚjRÔdLs 
 TX§\uLû[ çi¥V ÏÚjRÔdLs. 
   
 
®[dÏRp 
 
LY²jRp 
 
ªu LhP 
®[dL 
Lôh£ 
 
ÏÚjRÔ 
L°u 
YûLLs 
GjRû]? 
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LÚ ÏÚjRÔdLs : 
   LÚ ÏÚjRÔdLs ©[ôvvúPô£v¥Ûs[ JÚ 
Ød¡VUô] ùYtßTkÕ, U²R EP-p Es[ JÚ 
ØhûP ùNp JÚ ®kÕ êXm LÚÜtß 3 ØRp 5 
SôhLÞdÏ ©\Ï EÚYô] EsùNp§\u ùT\lTÓm. 
CVpXTô] Y[of£N«p EsùNp§Ws Esú[ 
SmØûPV GpXô §ÑdLs Utßm Eßl×Ls ùTÚdLm 
AûP¡u\]. G²àm ®gOô²Ls EsùNp§Ws 
©¬jùRÓdL Utßm £\l× BnYL ¨TkRû]L°p 
CkR ùNpLs Y[ÚmúTôÕ LÚ ÏÚjRÔdL°u 
Ti×Lû[ RdLûYjÕ ùLôsÞm. LÚ 
ÏÚjRÔdL°u TX§\uLs ØÝûUVôL 
EÚYôdLlThÓ EP-p Es[ JqùYôÚ ùNp-u 
YûLLs ùTÚdLm AûP¡u\]. B]ôp 
SgÑdùLô¥ Utßm ùRôl×sùLô¥ ùTÚdLm 
AûPY§pûX. 
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Ï±l©hP §ÑdL°u ÏÚjRÔdLs : 
   Ï±l©hP §ÑdL°u ÏÚjRÔdLs (úUÛm 
EPÛdÏ¬V ApXÕ YVÕ ÏÚjRÔdLs) LÚ 
ÏÚjRÔdLû[ ®P £\lTô]Õ. ùTôÕYôL CkR 
ÏÚjRÔ Ï±l©hP §Ñ ApXÕ Eßl×dÏs 
ùYqúYß ùNp YûLLû[ EÚYôdL Ø¥Ùm. 
  ERôWQUôL GÛm× Uwû_«-ÚkÕ EÚYôÏm 
UWTÔdL°u êXm £YlTÔdLs, 
ùYsû[VÔdLs Utßm CWjR RhÓL°u EVoÜ 
CYtû\ EÚYôdL Ø¥Ùm. 
  U²R EP-p §Ñ®u Ï±l©hP ÏÚjRÔdLû[ 
LiÓ©¥lTÕ ªL L¥]Uô]Õ. 
 
CûPÖûZj §Ñ ÏÚjRÔdLs : 
  TX ÏÚjRÔdLs ùTôÕYôL GÛm× 
Uwû_«-ÚkÕ EÚYôdLlTÓ¡u\]. CûYLs 
ùLôÝl× RuûUÙûPV §Ñ, GÛmTôd¡ Utßm 
RûNSôoLs G] úYßTÓjRlTÓ¡u\]. 
CûPÖûZj§Ñ ÏÚjRÔ CWjRm, LÚØhûP ÏZôn, 
LÚ LpÄWp Utßm ÖûWÂWp G] ©¬jùRÓdL 
Ø¥Ùm. 
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TX§\uLû[ çiPlThP ÏÚjRÔdLs : 
   TX§\uLû[ çiPlThP ÏÚjRÔdLs LÚ 
ÏÚjRÔdLû[ úTôp E«WÔdL°u úRôpùNpLs, 
Ï±l©hP §Ñ ùNpLs, Uôt±VRu êXUôL 
BnYLj§p ERÜ¡u\]. CkR YûLVô] 
ùNpL°u êXm ®gOô²Ls NôRôWQ Y[of£ 
Utßm úSôn ùRôPe¡V LôXm ØRp ARu 
Øuú]t\jûR Tt± úUÛm A±V Ød¡V 
LÚ®L[ôL Es[]. ×§V UÚkÕLs Utßm 
£¡fûNdLô] úNôRû] TVàs[RôL CÚdÏm 
Gußm A±¡u\]. 
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7 
 
 
6 ¨ª 
PeLs 
 
ÏÚjRÔ 
வின் 
பண்பு ள் 
  
 
ÏÚjRÔ®u Ti×Ls : 
 
 
 
   
 
 
    ÏÚjRÔdLs EP-p Ut\ YûLVô] 
ùNpLL°-ÚkÕ úYßTÓ¡u\]. Aû]jÕ 
ÏÚjRÔdLÞm ùTôÕYô] êuß Ti×Lû[ 
ùLôiÓ Es[Õ. 
 ÏÚjRÔdLs ¿iP LôXj§tÏ ReLû[ 
©[Ü Utßm ×Õl©dÏm §\u ùLôiPûY. 
 ÏÚjRÔdLs GkR®RUô] £\l× 
Ti×Lû[Ùm ùLôiPÕ ApX. 
 ÏÚjRÔdLs A§LlT¥Vô] £\l× 
ùNpL°u YûLLû[ ùLôÓdL Ø¥Ùm. 
 
®[dÏRp 
 
 
LY²jRp 
 
 
ªu LhP 
®[dL 
Lôh£  
 
ÏÚjRÔ 
®u 
Ti×Ls 
Gu]? 
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8 
 
11 
¨ªPe
Ls 
 
ùRôl×s 
ùLô¥ 
CWjRj§u 
êXm 
£¡fûN 
úSônLû[ 
LQd 
¡ÓRp 
 
ùRôl×s ùLô¥ CWjR ÏÚjRÔdLs TX 
®RúSônLû[ ÏQlTÓjÕ¡u\]. 
  1989Bm BiÓ ØRu ØR-p ùRôl×sùLô¥ 
CWjRm. CWjR úNôûL CWjR ×tßúSôn Utßm ©\ 
CWjR úSônLs ÏZkûRLÞdÏ ùYt±LWUôL 
£¡fûN A°dLlThÓ YÚ¡\Õ. ClùTôÝÕ 
BWônf£Vô[oLs ùT¬VYoLÞdÏ áP CkR 
YûLVô] £¡fûN Øû\ûV TVuTÓjR Ø¥Ùm 
Gußm áß¡\ôoLs. 
  CWjR ùYsû[VÔdLs ×tßúSôn ¨Q¿o 
Sô[l×tßúSôn Utßm ©\ CWjR ×tßúSônLs 
 BWmT ¨ûX«p Es[ ûT@©ú]ôûP©d 
CWjR ×tßúSôn 
 BWmT ¨ûX«p Es[ ¨Q¿o ×tßúSôn 
 BWmT¨ûX«p Es[ ûUúXô´²v CWjR 
×tßúSôn. 
 
 
®[dÏRp 
 
LY²jRp 
  
ªu LhP 
®[dL 
Lôh£ 
 
GlT¥ 
ùRôl×s 
ùLô¥ 
CWjRj§u 
êXm 
úSônLs 
ÏQl 
TÓjRl 
TÓ¡u\]? 
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 BWmT ¨ûX«p Es[ úYßTÓj§LôhP 
Ø¥VôL CWjR ×tßúSôn. 
 Ø§of£VûPkRYoL°u ¥ ùNp CWjR 
×tßúSôn. 
 Øt±V ¨ûX«p Es[ -múTôûNû¥d 
×tßúSôn. 
 Øt±V ¨ûX«p Es[ ûUúXô´²v 
×tßúSôn. 
 ¨Q¿o ×tßúSôn 
 C[mYV§p Øt±V ¨ûX«p Es[ CWjR 
×tßúSôn. 
 TXYûLVô] GÛm× ×tßúSôn 
 ¨Q¿o YûLûV NôWôR ×tßúSôn 
 ÏÚ§¿o ùNp CWjR ×tßúSôn 
 CWjRl ùTÚm ×WRU¦ ªûLf úNôûL. 
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9 
 
10 
¨ªPe
Ls 
 
ÏÚjRÔ
Lû[ 
úNL¬dÏm 
SûPØû\
Lû[ 
®[dÏRp 
    
 ùRôl×sùLô¥ CWjRYe¡ úNL¬l× 
ûUVeLs Ck§Vô®p TpúYß 
CPeL[ô] ùNuû], ØmûT, ×ÕùPp-, 
×ú], ùLôpLjRô, ûaRWôTôj, ùTeLðo, 
ALURôTôj Utßm TX SLWeL°Ûm 
Es[]. 
  
வருடாந்
திர 
கெமிப்பு 
 
21 
வருடம் 
 
ஆயுட் ாலம் 
 
ஜெய்மு
னறக் 
 ட்டணம் 
 
10,000 
 
10,000 
 
10,000 
 
பதிவுக் 
 ட்டணம் 
 
3,500/ 
மாதம் 
 
25,000 
(ஒகர 
தவனண) 
 
40,000 (ஒகர 
தவனண) 
 
 
 
®[dÏRp 
 
LY²jRp 
 
ªu LhP 
®[dL 
Lôh£ 
 
GqY[Ü 
CWjRm 
ÏZkûR 
L°Pm 
CÚkÕ 
GÓdLlTÓ
¡u\]? 
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 A±®V-u êXm ªL Ïû\kR 
ùYlT¨ûX«p TôÕLôdLlThÓ TX 
NLôlReL[ôLÜm Nôj§VUô]RôLÜm, 
CÚdÏm. CkR ùRôl×sùLô¥ 
ÏÚjRÔdLs 23 BiÓLÞdÏ ©\Ï 
Cuàm Nôj§VUô]Õ Guß Eß§ 
ùNnVlTÓ¡\Õ. 
 Ye¡L°p úNL¬dLlTÓm ùRôl×sùLô¥ 
CWjRj§u NWôN¬ A[Ü 60ª- ApXÕ 2 
AÜuv. 
 UÚjÕYUû]«p 1 - 6 UôR 
CûPùY°«p SgÑdùLô¥ ÏÚjRÔdLs 
úNL¬l× ùRôPoTôL úNûY ûUUVeL°p 
ùR¬®dL úYiÓm. 
 LolTLôX RônUôoLs Ïß¡V LôX 
AYLôNj§p ùRôl×sùLô¥ 
ÏÚjRÔdLs úNL¬l× Tt± LûP£  
 
GkR 
YûLVô] 
ùYlT¨ûX
«p ÏÚj 
RÔdLs 
TôÕLôdLl
TÓ¡u\].  
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úSWj§XôYÕ A±®dL úYiÓm. 
 ùLôûP A°lTYoL°PªÚkÕ Jl×Rp 
ùTßRp. 
        úSôVô°«Pm ùNVpØû\ûV Tt± ®[dÏL. 
 RônUôoL°u ÑLlT©WNYm ApXÕ AßûY 
£¡fûN ©WNYj§u êXm ©\dLlTÓm 
ÏZkûRL°-ÚkÕ ùT\lTÓm 
ÏÚjRÔdLs ªLÜm TôÕLôlTôLÜm, 
Y-Vt\ Øû\«Ûm úNL¬dLlTÓ¡u\]. 
 
 
 ÏZkûR ©\kRÜPu ùRôl×sùLô¥ ùYhPl 
TÓ¡\Õ. 
 JÚ £\l× CWjR ûT«p ùRôl×sùLô¥ 
CWjRm úNL¬dLlThÓ Ï±«PlTÓ¡\Õ. 
 ùRôl×s SWm©p F£ ùNÛj§ CWjRm 
GÓdLlThÓ CWjRlûT«p 
úNL¬dLlTÓ¡\Õ. 
 
ÏÚjRÔd
Ls GlT¥ 
GÓdLl 
TÓ¡\Õ? 
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 ÏÚjRÔdLs GÓdLlThÓ §WY 
ûShW_²p 196.C Ïl©«p úNªdLlTÓ¡\Õ. 
 CWjRj§u A[Ü 70 ª- ¤ GûP 
SgÑdùLô¥, CWjRj§u A[Ü 45 ª- ¤ 
ÏZkûR«u GûP. 
 UÚjÕY¬u ER®ÙPu RiÓ§Ñ 
ùRôl×sùLô¥ ÑjRm ùNnÕ ûalTô¬] 
ûTL°u êXm úNL¬dLlTÓ¡\Õ. 
 RiÓ§Ñ ùRôl×sùLô¥ ÑjRm ùNnÕ 
úNL¬dLlThÓ JÚ £±V ÏÓûY«p 
ûYdLlThÓ BnYLj§tÏ AàlTlTÓ¡\Õ. 
CÕ 10 ¨ªPj§tÏs BnYLj§p 
JlTûPdLlTÓ¡\Õ. 
 ÏZkûR ©WNYj§tÏ ©\Ï ùRôl×sùLô¥ 
CWjRm SgÑdùLô¥«p Gg£Ùs[ CWjRm 
úNL¬dLlTÓ¡u\]. 
 _ô¥«p úNL¬dLlThP ÏÚjRÔLdL°u  
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ùY°l×\j§p Rôn Utßm ÏZkûR«u 
ØÝûUVô] RLYpLs APe¡V  Øu 
Af£PlThP ®[dL ºhÓ 
CûQdLlTÓ¡\Õ. 
 CûYLs NWôN¬ A[ûY ®P ªL ùT¬V 
90-100ª- ApXÕ 3 AÜuv CWjR A[Ü 
ùRôPo×ûPVÕ. 
 ùRôl×sùLô¥ CWjRm ©\kR 48 U¦ 
úSWj§p GÓdLlThÓ Ye¡L°p 
úNL¬dLlThÓ YÚ¡u\]. 
 ¡ûWúVô TôÕLôl× ùNVpØû\«p 
ÏÚjRÔdLs ùRôl×sùLô¥ CWjRj§p 
CÚkÕ GÓdLlThÓ éw´Vm ùYlT¨ûX«p 
(196.c) Tj§WUôL TôÕLôdLlTÓ¡\Õ. 
 ùRôl×sùLô¥ ÏÚjRÔdLÞdÏ GkR ®R 
LôXôY§ úR§Ùm CpûX. YôrSôs 
ØÝYÕm CûY TXu A°d¡\Õ. 
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Ø¥ÜûW :  CÕYûW Sôm ùNpLs Gu\ôp Gu], ùNpL°u YûLLs, ÏÚjRÔ GlT¥ úNªdLlTÓ¡u\]. ÏÚjRÔ 
Ye¡Ls, ÏÚjRÔ®u SuûULs Utßm Ïû\TôÓLs TdL ®û[ÜLs Utßm ùN®-V¬u TeÏ Gu] GuTûR Tt± 
Tôoj§Úd¡ú\ôm. 
¾oUô]m :  CkR TôP§hPj§-ÚkÕ Sôu ÏÚjRÔ £¡fûNûV Tt± ®¬YôLÜm úUÛm ÏÚjRÔ Ye¡ûV Tt±Ùm 
LtßùLôiúPôm. CÕ GuàûPV YôrdûL Øuú]t\j§tÏ ªLÜm TVàs[RôL CÚdÏm Guß Sm×¡ú\u. ÏÚjRÔ 
£¡fûN«u BnÜ A±dûL, RtúTôûRV Utßm G§oLôX Øuú]t\j§tÏ TX Ï±l©PjRdL SuûULû[ 
ùLôiÓ«Úd¡u\]. 
 ùTtú\ôoLs, ÏZkûRLs YVÕ YWmûT 
GhÓm ùTôÝÕ ÏÚjRÔdLû[ 
TVuTÓjÕYRtÏ NhPéoYUô] 
A§LôWjûR ùTß¡u\]. 
 N¬Vô] Øû\«p T§ÜLû[ TWôU¬jRp. 
 CWL£VUô] Øû\«p TôÕLôd¡u\]. 
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APPENDIX XI 
PART 1 : DEMOGRAPHIC VARIABLES 
Structured Questionnaire Regarding Demographic Data From Antenatal 
Mother. 
Instruction: 
Place a tick mark in the corresponding space given for 7 questions below. 
1. Age of the mother  
    a. 21-25          [  ] 
    b.26-30          [  ] 
    c.31-35          [  ] 
    d.36-40          [  ] 
2.Religion 
    a. Hindu          [  ] 
    b.Muslim          [  ] 
    c.Christian          [  ] 
    d.others          [  ] 
3.Gravida of the mother  
   a. gravida one         [  ] 
   b.gravida two         [  ] 
  c.Multigravida         [  ] 
4.Education  
   a.Secondary School Education       [  ]  
   b.Higher Secondary Education       [  ] 
   c.Graduate          [  ] 
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5. Occupation 
    a.Home maker         [  ] 
    b.Government Employee        [  ] 
    c. Private Employee        [  ] 
    d. Self –employee/Bussiness       [  ] 
6. Type of  family 
    a. Nuclear family         [  ] 
    b. Joint family         [  ] 
7. Previous knowledge source of stem cell therapy     
   a. Mass media         [  ] 
   b.Health workers         [  ] 
   c.Peer group          [  ] 
   d.None          [  ] 
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PART 2 : STRUCTURED KNOWLEDGE QUESTIONNAIRE REGARDING 
CORD BLOOD STEM CELL THERAPHY AMOUNG ANTENATAL 
MOTHERS. 
Instruction: 
The tool consist of 40 questions and each question consists of  multiple options and 
one is the appropriate answer. Place a tick mark in the corresponding space given 
below: 
1. The basic form of  life is ? 
a. Cell         [  ] 
b. Mitochondria        [  ] 
c. Plasma                                        [  ] 
d. DNA                                                                         [  ]  
2. What are the two major types of cells ?  
a. Muscle cells & secretary cells      [  ] 
b. Stem cells & normal cells       [  ] 
c. Bone cells & cartilage cells      [  ] 
d. Nerve cells & epithelial cells      [  ]  
3. What is a stem cell?  
a.A cell that can make copies of itself and make more specialized types of cell
           
          [  ] 
b.A cell have the capacity to develop into particular  type of cell      [  ] 
c.A cell wont have capable to renew new cell                                           [  ] 
d. A cell have capable to renew all type of cell in the body at the time    [  ] 
 
4. What are all the types of  normal cell division? 
a. DNA replication         [  ] 
b. Zygote formation         [  ] 
c. Mitosis and Meiosis       [  ] 
d. No division        [  ] 
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5. One of the key differences in mitosis is  ? 
 a. A single cell divides into two cells       [  ]
 b. A single cell divides into four cells      [  ]
 c. A single cell divides into six cells       [  ] 
 d, A single cell divides into eight cells      [  ]  
 
6. What is meiosis? 
         a. Cell divides into two  cells that have a half the number of  chromosomes     [  ]                                                                                          
         b. Cell divides into four  cells that have a half the number of  chromosomes    [  ] 
         c. Cell divides into six cells that have a half the number of  chromosomes       [  ] 
         d. Cell divides into eight  cells that have a half the number of chromosomes   [  ] 
7. Cord blood cells are formed by? 
a. Embryonic stem cells       [  ] 
b.Tissue-specific stem cells       [  ] 
c.Mesenchymal stem cells       [  ] 
d.Induced pluripotent stem cells      [  ] 
8. How cord blood transplant performed?  
a. Infused through the patient blood stream     [  ] 
b. Infused through the  Iv fluids      [  ] 
c. Infused through the blood transfusion     [  ] 
d. Infused through the born marrow      [  ] 
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9. What is the British law which regulates the storage and use of embryos called?  
a. Human Embryo Protection Act      [  ] 
b. Human Fertilisation and Embryology Act     [  ] 
c. Human Fertilisation and Embryology Law    [  ] 
d. Embryo Protection Act      [  ] 
10. when the cord blood transplant was first  performed ? 
a. 1990         [  ] 
b. 1991         [  ] 
c. 1992         [  ] 
d. 1993         [  ] 
 11 .   How many diseases can be treated by cord blood stem cells ? 
a.approx 50 life –threatening diseases      [  ] 
b. approx 60 life –threatening diseases      [  ] 
c. approx 70 life –threatening diseases     [  ]  
d. approx 80 life –threatening diseases     [  ]  
12. Embryonic stem cells can differentiate into which types of cell?  
a.Only brain stem cells and specialized brain cells    [  ]  
b.All types of specialized cells in the body      [  ] 
c.Only cells that can produce insulin       [  ] 
d.Only cells that can produce artificial skin      [  ] 
13. Embryonic stem cells for treating such immune disorders as ? 
a. Elephantiasis and whooping cough      [  ]   
 b. Type 1 diabetes and rheumatoid arthritis      [  ]   
c. Addison‘s disease and vaginitis      [  ]                                   
d. Chicken pox and small pox          [  ]       
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14. Which type of stem cell can be difficult to find in the human body ?  
a. Embryonic stem cell        [  ] 
b. Tissue-specific stem cell        [  ] 
c. Mesenchymal stem cell        [  ] 
d. Induced pluripotent stem cell       [  ] 
15 .Where the mesenchymal stem cell found?  
a. Bone marrow        [  ] 
b. Liver         [  ] 
c. Brain         [  ] 
d. Tissue         [  ]  
16. Induced pluripotent stem cells have the same developmental potential as? 
a. Hematopoietic stem cells       [  ]  
b.Neuronal stem cells        [  ] 
c.Embryonic stem cells        [  ] 
d.Dental pulp stem cell            [  ]  
17. What is the most accurate statement about human pluripotent cells?  
a. Can make all know types of human cells     [  ] 
b. Only embryonic stem cells fit       [  ] 
c. Can make all types of human cells except extra embryonic tissues  [  ] 
d. Can differentiate and self-renew      [  ] 
18. Stem cells are capable of dividing and renewing themselves for  ? 
a. Lesser periods                             [  ]  
b.Longer periods                    [  ] 
c.With in a minute          [  ] 
d.No periods                            [  ]  
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19. What is the amount of blood forming stem cells  in the healthy full- term  
babies ? 
a. Over a 1000 stem cells       [  ] 
b. Over a 10000 stem cells       [  ] 
c Over a 100000 stem cells                  [  ] 
d. Over a 1000000 stem cells       [  ] 
 
20.Umbilical cord blood has been used successfully to treat children with ? 
a. Typhoid and tuberculosis                                                                   [  ]  
b. poliomyelitis and diphtheria                                                             [  ] 
c.Leukemia and anemia                                                            [  ] 
d.Diarrhoea and dysentery                                                        [  ]  
                                                     
21.Haematopoietic stem cells that can be obtained from ? 
            a.White blood                                                                                         [  ] 
b.Red blood         [  ] 
c. Cord blood                                                                                        [  ]                
d. placenta         [  ]         
22.Which type of patients must receiving stem cell transplants from donors ? 
            a. Diarrhea                                                                                             [  ] 
          b. Leukemia                                                                                           [  ] 
          c. Poliomyelitis                                                                                     [  ] 
            d. kala azar                                                                                             [  ] 
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23. Cord blood stem cells can be matched for which type of recipients ? 
            a. friends                                                                                                [  ]   
            b. neighbors                                                                                           [  ]  
            c. siblings                                                                                               [  ]   
            d. Others                                                                                                 [  ] 
24. Where is the umbilical cord blood bank collection centers are available in 
tamilnadu ? 
a.Coimbatore                         [  ]  
b.Chennai                     [  ] 
c.Madurai                    [  ] 
d.Salem                                         [  ]  
25.What is the fixed & transparent amount for processing fee ?  
a.Rs. 32000/-          [  ] 
b.Rs. 27000/-          [  ] 
c.Rs. 50000/-          [  ] 
d.Rs. 35000/-          [  ] 
26. How long the cord blood stem cells are viable?  
a.after being frozen 23 + years      [  ] 
b.after being frozen 20 +  yrs        [  ] 
c.after being frozen 15 +  yrs        [  ] 
d.after being frozen 30  + yrs        [  ] 
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27. Who will intimate to the service centers regarding placental  stem cell collection?   
a. Hospital                                                  [  ] 
 b. Friends & relatives                                  [  ] 
 c. Donor                           [  ]
 d. Public                       [  ] 
28.when will the hospital should intimate to the donors regarding cord blood  
     collection   ?   
a.Upto 1st  trimester                             [  ] 
b. Upto 2nd trimester                      [  ] 
c. Prior admission to the labour room     [  ] 
d.At the time of delivery       [  ] 
29. Who can give the consent for cord blood collection?  
a. Husband         [  ] 
b. Parents         [  ] 
c. Donors          [  ] 
d. Relatives         [  ] 
30. In which type of delivery cord blood collection can be performed ?  
a. Caesarean section         [  ] 
b. Vaginal birth         [  ] 
c. Normal Veginal births with instruments       [  ] 
d. Caesarean section/veginal birth        [  ] 
31. When you will collect umbilical cord blood stem cells ?. 
 a. 30 mts before delivery       [  ] 
            b. 30 mts after delivery       [  ] 
           c. within 10 mts after delivery of the baby               [  ] 
d. within 10 mts after delivery of the placenta              [  ] 
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32. Umbilical cord blood is collected from ?  
a. Placenta      [  ] 
b. Placental cord unit                                                                  [  ] 
c. Umbilical artery                           [  ] 
d. Blood which is comes through the cervix      [  ] 
33. What is the role for the obstetrician or midwife to safe guard the collection kit? 
a. Basic details of the mother        [  ]    
b. Basic details of the baby        [  ]    
c. Basic details of the hospital       [  ]  
d. Full details of the mother & baby        [  ] 
34. How much amount of blood should be collected from baby‘s umbilical cord? 
a. 60 ml         [  ] 
b. 70 ml         [  ] 
c. 80 ml         [  ] 
d. 90ml         [  ] 
35. What is the temperature to store stem cells during transportation ?  
a. 15 °C  to 25 °C        [  ] 
b. 20°C to 30°C        [  ] 
c. 30 °C to 40°C         [  ] 
d. 40°C to 50°C        [  ] 
36. The collected sample is picked up from hospital and transported to lab by? 
 a. Within 48 hours        [  ]
 b. Within 24 hours.         [  ]
 c. Within 50 hours.         [  ]
 d. Within 20 years.        [  ] 
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 37. What is the technique to preserve the stem cells?   
a .Cryopreservative technique      [  ] 
 b .Presevative technique       [  ] 
 c .Refregirator         [  ]
 d .colonization        [  ] 
38.which of the following Umblical cord blood stem cells are preserved at? 
 a. -196
o 
c         [  ] 
 b.-186
 o 
c         [  ] 
 c.-176
 o 
c         [  ] 
d.-166
 o 
c                                                                     [  ] 
39.What is the expiration date for stem cells after preservation? 
 a. No fixed date.         [  ] 
 b.0-5 years.          [  ] 
 c.5- 10 years.          [  ] 
 d. 10-20 years.         [  ] 
40. Who is the legal authority for the collected cord blood ? 
 a. Parents.          [  ] 
 b. Relatives          [  ] 
          c. Hospital                                                                                      [  ]                                                             
 d. Parents until the child becomes major                                                 [  ] 
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PART 3: LIKERT ATTITUDE SCALE REGARDING CORD BLOOD STEM 
CELL THERAPY AMONG ANTENATAL MOTHERS: 
INSTRUCTIONS: 
The tool consists of 20 questions and each question consists of multiple options and 
one is the appropriate answer. Place a tick mark in the corresponding space given 
below: 
s. no question Strongly 
agree 
      
 
     (5) 
Agree 
 
 
 
     (4) 
Neither 
agree 
nor 
disagree 
    (3) 
Disagree 
 
 
 
     (2) 
Strongly 
disagree 
 
 
     (1) 
1 
 
 
 
 
2 
 
 
 
 
3 
 
 
4 
 
 
 
5 
 
 
6 
 
 
 
7 
 
 
 
8 
 
Stem cells therapy are 
risk free, Because it may 
come from your own 
body 
 
During cord blood 
collection, the baby is 
not harmed any way. 
 
Stem cells are helped to 
treat many disease 
condition 
 
Can we able to store 
stem cells for a longer 
period. 
 
Stem cells are derived 
from placenta also 
 
Adult stem cells are 
found only in bone 
marrow 
 
In a clinical practice 
advice the mother  to 
store the stem cells for 
further purpose 
 
Embryonic stem cells are 
obtained from the inner 
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9 
 
 
 
 
 
 
 
 
10 
 
 
 
 
11 
 
 
 
12 
 
 
 
13 
 
 
 
14 
 
 
15 
 
 
 
16 
 
 
 
17 
 
 
18 
 
 
cell mass of the 
blastocyst. 
 
It is really important to 
find treatment for 
diabetes, heart disease, 
and Parkinson as quickly 
as possible, even if it 
means destroying 
embryos 
to do so. 
 
It would be terrible if 
cures were delayed 
because of policies that 
make embryonic stem 
cell research difficult. 
 
Using umbilical cord 
blood  stem cells is easy 
compare to embryo 
 
Umbilical cord blood is a  
rich source for stem 
cells. 
 
 
Umblical cord blood 
stem cells can be 
collected at the time of 
birth. 
 
If cost is affordable I can 
pay to store my baby 
cord blood. 
 
Your baby umbilical 
cord blood could be a 
potential match for 
siblings also. 
 
Embryonic stem cell 
research is illegal and 
unnecessary. 
 
Stem cell can be 
preserved for a lesser 
period. 
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19 
 
 
 
 
20 
 
Does your baby affected 
by collecting umbilical 
cord blood stem cells. 
 
Thalassemia,Leukaemia, 
Lymphoma can be 
treated by stem cell 
therapy. 
 
Stem cell transplantation 
should be widely 
practiced 
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PART II -SCORE KEY FOR STRUCTURED KNOWLEDGE 
QUESTIONNAIRE 
        QUESTION NO                  ANSWER                     SCORE 
1 a 1 
2 b 1 
3 a 1 
4 c 1 
5 a 1 
6 a 1 
7 a 1 
8 a 1 
9 a 1 
10 a 1 
11 d 1 
12 b 1 
13 b 1 
14 b 1 
15 a 1 
16 c 1 
17 c 1 
18 b 1 
19 d 1 
20 c 1 
21 c 1 
22 b 1 
23 c 1 
24 b 1 
25 d 1 
26 a 1 
27 a 1 
28 c 1 
 141 
 
29 c 1 
30 d 1 
31 c 1 
32 b 1 
33 d 1 
34 d 1 
35 a 1 
36 a 1 
37 a 1 
38 a 1 
39 a 1 
40 d 1 
 
       SCORE: 40 
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PART - III 
LIKERT ATTITUDE SCALE REGARDING CORD BLOOD STEM CELL 
THERAPY AMONG ANTENATAL MOTHERS 
S.No Question Strongly 
agree 
 
(5) 
Agree 
 
 
(4) 
Neither 
agree nor 
disagree 
(3) 
Disagree 
 
 
(2) 
Strongly 
Disagree 
 
(1) 
1 1      
2 2      
3 3      
4 4      
5 5      
6 6      
7 7      
8 8      
9 9      
10 10      
11 11      
12 12      
13 13      
14 14      
15 15      
16 16      
17 17      
18 18      
19 19      
20 20      
NOTE: 
 This is for positive statements. It will be reversible for negative statements. 
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APPENDIX XII 
jfty; Nrfhpg;G tpdhf;fs; 
gphpT – m 
jdp egh; jfty; 
mwpTiu: 
 Njh;thsh; khjphp vz; mspf;Fk; gjpiy njhlh;ghd ,lj;jpy; [] nra;thh;. 
1. jhap;d; taJ 
  (m) 21 Kjy; 25 tajpw;Fs;      [   ] 
  (M) 26 Kjy; 30 tajpw;Fs;      [   ] 
  (,) 31 Kjy; 35 tajpw;Fs;      [   ] 
  (<) 36 Kjy; 40 tajpw;Fs;      [   ] 
2.  kjk; 
  (m) ,e;J         [   ] 
  (M) K];yPk;        [   ] 
  (,) fpwp];Jth;        [   ] 
  (<) gpw kjj;jth;fs;       [   ] 
3.  jha;ik epiy 
  (m) Kjy; jlitahf fUTw;w ngz;     [   ] 
  (M) ,uz;lhtJ Kiwahf fUTw;w ngz;    [   ] 
  (,) gy Kiw fUTw;w ngz;      [   ] 
4.  fy;tp jFjp 
  (m) ,ilepiy fy;tp       [   ] 
  (M) cah; epiy fy;tp       [   ] 
  (,) gl;lg;gbg;G        [   ] 
5. njhopy;  
  (m) tPl;L Ntiy         [   ] 
  (M) muR mYtyh;       [   ] 
  (,) jdpahh; Copah;       [   ] 
  (<) Ranjhopy; / tpahghuk;      [   ] 
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6. FLk;gj;jpd; tiffs; 
  (m) jdp FLk;gk;        [   ] 
  (M) $l;Lf; FLk;gk;       [   ] 
7.  FUj;jZ rpfpr;ir gw;wpa mwpT vjd;Kyk; ngwg;gl;lJ 
  (m) jfty; njhlh;G rhjdq;fs;     [   ] 
  (M) Rfhjhu mYtyh;fs;      [   ] 
  (,) ez;gh;fs;          [   ] 
  (<) ,tw;wpy; VJkpy;iy       [   ] 
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gphpT – M 
 fh;gfhy jha;khh;fSf;fpilNa FUj;jZ rpfpr;iria gw;wpa mwpTjpwid 
fz;lwpAk; tpdhf;fs;: 
mwpTiu: 
 fPNo 40 tpdhf;fs; nfhLf;fg;gl;Ls;sd xt;nthU tpdhtpw;Fk; ehd;F gjpy;fs; 
jug;gl;Ls;sd. ,jpy; xd;W kl;Lk; rhpahd gjpy;. fh;gfhy jha;khh;fs; mspf;Fk; 
gjpiy njhlh;ghd ,lj;jpy; Njh;thsh; [] FwpaPLthh;. 
 
1. caphpd; mbg;gil tbtk; vd;d? 
  (m) nry;          [   ] 
  (M) ikl;Nlhfhz;Bhpah        [   ] 
  (,) gpsh];kh           [   ] 
  (<) b.vd;.V          [   ] 
 
2. nry;fspd; ,uz;L Kf;fpa tiffs; vd;d? 
  (m) jir nry;fs; kw;Wk; nrayhsh; nry;fs;    [   ] 
  (M) FUj;jZ nry;fs; kw;Wk; rhjhuz nry;fs;    [   ] 
  (,) vYk;G nry;fs; kw;Wk; FUj;njYk;G nry;fs;    [   ] 
  (<) euk;G nry;fs; kw;Wk; vgpjPypay; nry;fs;     [   ] 
    
3. FUj;jZ nry; vd;why; vd;d? 
  (m) xU nry; mjd; vz;zpf;ifia ngUf;fp nfhz;Lk; kw;Wk; 
      rpwg;G tifahd nry;fis cUthf;ffpd;wd.    [   ] 
  (M) xU nry;fSf;F Fwpgpl;l tifahd nry;fis cUthf;Fk;  
      jd;ik nfhz;lJ.        [   ] 
  (,) xU nry;fSf;F Gjpa nry;fis GJgpf;Fk; jd;ik  
      fpilahJ.         [   ] 
  (<) xU nry;fSf;F clypy; cs;s midj;J nry;fis xNu Neuj;jpy; 
     GJgpf;Fk; jd;ik nfhz;lJ.      [   ] 
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4. rhuhuz nry; gphptpd; tiffs;? 
  (m) b.vd;.V gpujpnra;if .       [   ] 
  (M) ,izTg;nghUs; cUthf;fk.;      [   ] 
  (,) ,iyAUg;gpgpT kw;Wk; xLf;fw;gphpT.     [   ] 
  (<) ve;j gphpTk; ,y;iy.        [   ] 
 
5. ,ioAUg;gphptpd; Kf;fpa NtWghL? 
  (m) xU xw;iw nry; ,uz;L nry;fshf gphpfpd;wd.    [   ] 
  (M) xU xw;iw nry; ehd;F nry;fshf gphpfpd;wd.    [   ] 
  (,) xU xw;iw nry; MW nry;fshf gphpfpd;wd.    [   ] 
  (<) xU xw;iw nry; vl;L nry;fshf gphpfpd;wd.      [   ] 
 
6. xLf;fw;gphpT vd;why; vd;d? 
  (m) xU nry; ,uz;L nry;fshf gphptile;J NkYk; ghjp  
vz;zpf;ifapyhd FNuhNkhNrhk;fis nfhz;Ls;sJ.    [   ] 
  (M)  xU nry; ehd;F nry;fshf gphptile;J NkYk; ghjp  
vz;zpf;ifapyhd FNuhNkhNrhk;fis nfhz;Ls;sJ.     [   ] 
  (,) xU nry; MW nry;fshf gphptile;J NkYk; ghjp  
vz;zpf;ifapyhd FNuhNkhNrhk;fis nfhz;Ls;sJ.    [   ] 
  (<) xU nry; vl;L nry;fshf gphptile;J NkYk; ghjp  
vz;zpf;ifapyhd FNuhNkhNrhk;fis nfhz;Ls;sJ.     [   ] 
7. njhg;Gs; nfhb ,uj;j nry;fs; vjpypUe;J cUthfpd;wd? 
  (m) fU FUj;jZf;fs.;        [   ] 
  (M) jpR Fwpg;gpl;l FUj;jZf;fs;.      [   ] 
  (,) ,ilEioj;jpR FUj;jZf;fs;.      [   ] 
  (<) gyjpwd;fis J}z;ba FUj;jZf;fs;.     [   ] 
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8. njhg;Gs;nfhb ,uj;j Xl;lj;jpy; cl;nrYj;Jjy; 
  (m) Nehahspapd; ,uj;j Xl;lj;jpy; cl;nrYj;Jjy;.    [   ] 
  (M) jputq;fspd; %yk; euk;Gfspy; cl;nrYj;Jjy;.    [   ] 
  (,) ,uj;j Vw;wj;jpd; %yk; cl;nrYj;Jjy;.     [   ] 
  (<) vYk;G k[;i[apd; %yk; cl;nrYj;Jjy;.     [   ] 
 
9. Nrkpg;G kw;Wk; fUf;fs; gad;gLj;Jk; gphpl;b\; rl;lk; vd;d? 
  (m) kdpj fU ghJfhg;G rl;lk;.      [   ] 
  (M) kdpj fUj;jhpj;jy; rl;lk;.       [   ] 
  (,) kdpj fUj;jhpj;jy; kw;Wk; fUtpay; Ma;T rl;lk;   [   ] 
  (<) fU ghJfhg;G rl;lk;        [   ] 
 
10. njhg;Gs;nfhb ,uj;j khw;W Kiwia Kjd;Kjypy; vg;nghOJ epfo;j;jg;gl;lJ? 
  (m) 1990.          [   ] 
  (M) 1991.          [   ] 
  (,) 1992.          [   ] 
  (<) 1993.          [   ] 
 
11. njhg;Gs; nfhb FUj;jZf;fspd; %yk; vj;jid Neha;fs; Fzg;gLj;jgLfpd;wd? 
  (m) Rkhh; 50 mr;RWj;Jk; Neha;fs;      [   ] 
  (M) Rkhh; 60 mr;RWj;Jk; Neha;fs;      [   ] 
  (,) Rkhh; 70 mr;RWj;Jk; Neha;fs;      [   ] 
  (<) Rkhh; 80 mr;RWj;Jk; Neha;fs;      [   ] 
 
12. ve;j tifahd nry;fspd; %yk; fUFUj;jZf;fs; NtWgLfpd;wd? 
  (m) %is FUj;jZf;fs; kw;Wk; rpwg;G %is nry;fs.;   [   ] 
  (M) clypd; vy;yh tifahd rpwg;G nry;fSk;.    [   ] 
  (,) ,d;Rypid cw;gj;jp nra;Ak; nry;fs;.     [   ] 
  (<) nraw;if Kiwapdhy; Md Njhy; nry;fs;.    [   ] 
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13. FUj;jZf;fs; ve;j tifahd vjph;g;G Neha;fis Fzg;gLj;Jfpd;wd? 
  (m) ahidf;fhy; Neha; kw;Wk; ff;Fthd; ,Uky;.    [   ] 
  (M) tif 1 ePuopT kw;Wk; Klf;F thjk;.     [   ] 
  (,) Gzh;Gioaowrp Neha;fs;.       [   ] 
  (<) rpd;dk;ik kw;Wk; mk;ik.       [   ] 
 
14. ve;j tifahd FUj;jZf;fis kdpj clypy; fz;Lgpbg;gJ fbdkhdJ? 
  (m) fU FUj;jZf;fs;.        [   ] 
  (M) jpR Fwpg;gpl;l FUj;jZf;fs;.      [   ] 
  (,) ,ilEioj;jpR fUj;jZf;fs;.      [   ] 
  (<) gy jpwd;fis J}z;ba FUj;jZf;fs;.     [   ] 
 
15. ,ilEio FUj;jZf;fs; vq;Nf fhzg;gLfpwJ? 
  (m) vYk;G k[;i[.        [   ] 
  (M) fy;yPuy;.         [   ] 
  (,) %is.          [   ] 
  (<) jpR.          [   ] 
 
16. gyj;jpwd;fis J}z;lg;gl;l FUj;jZf;fs; mNj tsh;r;rp rhj;jpak; ,y;iy? 
  (m) FUjpahf;f FUj;jZf;fs;.       [   ] 
  (M) euk;gfs; rhh;e;j FUj;jZf;fs;.      [   ] 
  (,) fU FUj;jZf;fs;.        [   ] 
  (<) gw;$o; FUj;jZf;fs;.       [   ] 
17. kdpjdpd; gyjpwd; nry;fs; gw;wp kpfTk; Jy;ypakhd mwpf;if vd;why; vd;d? 
  (m) midj;J tifahd kdpj nry;fs;.     [   ] 
  (M) fU FUj;jZf;fs; kl;;Lk; nghUe;Jk;.     [   ] 
  (,) fU jpRf;fis jtpu midj;J tidahd kdpj nry;fs;.  [   ] 
  (<) NtWgLj;j$ba kw;Wk; jhdhf GJg;gpf;f $baJ.   [   ] 
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18. FUj;jZf;fspd; gpsT kw;Wk; GJg;gpf;Fk; jpwd; nfhz;lit vJ? 
  (m) kpf FWfpa fhyq;fspy;.       [   ] 
  (M) ePz;l fhyq;fspy;.        [   ] 
  (,) xU epkplj;jpy;.        [   ] 
  (<) ve;j tpj fhyq;fspYk; ,y;iy.      [   ] 
 
19. MNuhf;fpakhd Foe;ijfspd; clypy; cUthFk; ,uj;j FUj;jZtpd; msT 
  (m) 1>000-f;F Nkw;gl;l FUj;jZf;fs;.      [   ] 
  (M) 10>000-f;F Nkw;gl;l FUj;jZf;fs;.     [   ] 
  (,) 1>00>000-f;F Nkw;gl;l FUj;jZf;fs;.     [   ] 
  (<) 10>00>000-f;F Nkw;gl;l FUj;jZf;fs;.     [   ] 
 
20. Foe;ijfspd; ve;j tifahd Neha;fis njhg;Gs;nfhb ,uj;jj;jpd; %yk; 
ntw;wpfukhf Fzg;gLj;jgLfpd;wd? 
  (m) ilgha;L kw;Wk; fhrNeha;.       [   ] 
  (M) ,sk;gps;is thjk; kw;Wk; njhz;il mow;rp Neha;.   [   ] 
  (,) ,uj;j Gw;W Neha; kw;Wk; ,uj;jNrhif.     [   ] 
  (<) tapw;WNghf;F kw;Wk; tapw;WfLg;G.     [   ] 
 
21. FUjpahf;f FUj;jZf;fs; vjpypUe;J ngwg;gLfpwJ? 
  (m) ,uj;j nts;isaZf;fs;.       [   ] 
  (M) ,uj;j rptg;gZf;fs;.       [   ] 
  (,) njhg;Gs;nfhb ,uj;jk;.       [   ] 
  (<) eQ;Rf;nfhb.         [   ] 
22. ve;j tifahd NehahspfSf;F nfhilahsh;fsplkpUe;J FUj;jZf;fs; khw;W 
ngw Ntz;Lk;? 
  (m) tapw;WNghf;F.        [   ] 
  (M) ,uj;j Gw;WNeha;.        [   ] 
  (,) ,sk;gps;is thjk;.        [   ] 
  (<) fLq;fha;r;ry;.         [   ] 
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23. njhg;Gs;nfhb ,uj;j FUj;jZf;fs; nghUe;j ve;j tifia rhh;e;jtuhf ,Uf;f 
Ntz;Lk;? 
  (m) ez;gh;fs;.         [   ] 
  (M) mUfpy; cs;sth;fs;.       [   ] 
  (,) cld;gpwg;Gfs;.        [   ] 
  (<) kw;wth;fs;.         [   ] 
 
24. jkpo;ehl;by; njhg;Gs;nfhbapd; ,uj;jtq;fp Nrfhpg;G ikak; vq;F cs;sJ? 
  (m) Nfhak;Gj;J}h;.        [   ] 
  (M) nrd;id.           [   ] 
  (,) kJiu.         [   ] 
  (<) Nryk;.          [   ] 
 
25. epiyahd kw;Wk; nrayhf;f fl;lzk; msT vt;tsT? 
  (m) & 32>000.         [   ] 
  (M) & 27>000.           [   ] 
  (,) & 50>000.         [   ] 
  (<) & 35>000.         [   ] 
 
26. njhg;Gs;nfhb FUj;jZf;fs; vt;tsT fhyk; rhj;jpakhdJ? 
  (m) 23 Mz;LfSf;F Nkyhf ciwe;j epiyapy;.    [   ] 
  (M) 20 Mz;LfSf;F Nkyhf ciwe;j epiyapy;.    [   ] 
  (,) 15 Mz;LfSf;F Nkyhf ciwe;j epiyapy;.    [   ] 
  (<) 30 Mz;LfSf;F Nkyhf ciwe;j epiyapy;.    [   ] 
27. eQ;Rnfhb FUj;jZf;fs; Nrfhpg;G njhlh;ghd Nrit ikaq;fspy; ahh; njhptpf;f 
Ntz;Lk;? 
  (m) kUj;Jtkid.        [   ] 
  (M) ez;gh;fs; kw;Wk; cwtpdh;fs;.      [   ] 
  (,) jhdk; nfhLg;gth;.        [   ] 
  (<) nghJ kf;fs;.        [   ] 
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28. kUj;Jtkidapy; njhg;Gs;nfhb ,uj;j Nrfhpg;G njhlh;ghf ed;nfhilahsh;fs; 
ve;j khjj;jpy; njhptpf;f Ntz;Lk;? 
  (m) 3 khjj;jpy;.         [   ] 
  (M) 6 khjj;jpy;.         [   ] 
  (,) gpurt miwf;F nry;tjw;F Kd;G.     [   ] 
  (<) gpurtj;jpd; NghJ.        [   ] 
 
29. njhg;Gs;nfhb ,uj;j Nrfhpg;gpy; xg;Gjy; nfhLf;f ahh; KbAk;? 
  (m) fzth;.         [   ] 
  (M) ngw;Nwhh;fs;.         [   ] 
  (,) nfhilahsh;fs;.        [   ] 
  (<) cwtpdh;fs;.         [   ] 
 
30. njhg;Gs;nfhb ,uj;j Nrfhpg;G ve;j tifahd gpurtj;jpy; epfo;j;j KbAk;? 
  (m) mWit rpfpr;ir gpurtk;.       [   ] 
  (M) Rfgpurtk;.         [   ] 
  (,) MAjj;Jld; $ba Rfgpurtk;.      [   ] 
  (<) mWit rpfpr;ir gpurtk; / Rfgpurtk;.     [   ] 
 
31. vg;nghOJ njhg;Gs;nfhb FUj;jZf;fs; vLf;fgLfpwJ? 
  (m) gpurtj;jpw;F 30 epkplj;jpw;F gpwF.     [   ] 
  (M) gpurtk; Kbe;j  30 epkplj;jpw;F gpwF.     [   ] 
  (,) gpurtk; Kbe;j  10 epkplj;jpw;Fs;.     [   ] 
  (<) eQ;Rnfhb ntspte;j 10 epkplj;jpw;Fs;.      [   ] 
32. njhg;Gs;nfhb ,uj;jk; ve;j ,lj;jpypUe;J vLf;fgLfpwJ? 
  (m) eQ;Rnfhb.         [   ] 
  (M) eQRnfhb jz;L.        [   ] 
  (,) njhg;Gs; jkzp.        [   ] 
  (<) fUg;ig tha; %yk; tUk; ,uj;jk;.     [   ] 
 
 152 
 
33. Nrfhpf;fgl;l ngl;bia ghJfhg;ghf vLj;J nry;tjpy; kUj;Jthpd; gq;F? 
  (m) jhia gw;wp mbg;gil tptuq;fs;.      [   ] 
  (M) Foe;ijia gw;wpa mbg;gil tptuq;fs;.    [   ] 
  (,) kUj;Jtkid gw;wpa mbg;gil tptuq;fs;.    [   ] 
  (<) jha; kw;Wk; Foe;ij gw;wpa KO tptuq;fs;.    [   ] 
 
34. Foe;ijapd; njhg;Gs; nfhbapypUe;J vt;tsT ,uj;jk; vLf;fg;gLfpwJ? 
  (m) 60 kpy;yp.         [   ] 
  (M) 70 kpy;yp.         [   ] 
  (,) 80 kpy;yp.         [   ] 
  (<) 90 kpy;yp.         [   ] 
 
35. Nrfhpf;fgl;l FUj;jZf;fis NtnwhU ,lj;jpw;F vlj;J nry;Yk; NghJ ve;j 
ntg;gepiyapy; itf;fgLfpwJ? 
  (m) 15°C Kjy; 25°C tiu.       [   ] 
  (M) 20°C Kjy; 30°C tiu.       [   ] 
  (,) 30°C Kjy; 40°C tiu.       [   ] 
  (<) 40°C Kjy; 50°C tiu.       [   ] 
 
36. Nrfhpf;fg;gl;;l khjphp kUj;Jtkidapy; ,Ue;J vt;tsT Neuj;jpw;Fs; Ma;tfk; 
vLj;J nry;yg;gl Ntz;Lk;?  
  (m) 48 kzp Neuj;jpw;Fs;.       [   ] 
  (M) 24 kzp Neuj;jpw;Fs;.       [   ] 
  (,) 50 kzp Neuj;jpw;Fs;.       [   ] 
  (<) 20 kzp Neuj;jpw;Fs;.       [   ] 
 
37. FUj;jZf;fis ghJfhf;Fk; El;gk; vd;d? 
  (m) fpiuNah kpfFiwe;j ntg;gepiyapy;.     [   ] 
  (M) kpfFiwe;j ntg;gepiy;.       [   ] 
  (,) Fsph;rhjd ngl;b.        [   ] 
  (<) Gjpa ,lj;jpy;.        [   ] 
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38. njhg;gs;nfhb FUj;jZf;fs; gpd;tUk; ve;j ntg;gepiyapy; ghJfhf;fg;gLfpwJ? 
  (m) -196°C.          [   ] 
  (M) -186°C.          [   ] 
  (,) -176°C.          [   ] 
  (<) -166°C.          [   ] 
 
39. FUj;jZf;fis ghJfhg;gjw;fhd fhyhtjp Njjp vd;d? 
  (m) ve;j xU NjjpAk; ,y;iy.       [   ] 
  (M) 0-5 Mz;Lfs;.        [   ] 
  (,) 5-10 Mz;Lfs;.        [   ] 
  (<) 10-20 Mz;Lfs;.        [   ] 
 
40. Nrfhpf;fgl;l njhg;Gs;nfhbapd; ,uj;j rl;l mjpfhhp ahh;? 
  (m) ngw;Nwhh;fs;.         [   ] 
  (M) cwtpdh;fs;.         [   ] 
  (,) kUj;Jtkid.        [   ] 
  (<) Foe;ij gUtk; khWk; tiu.      [   ] 
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gphpT - , 
 fh;gfhy jha;khh;fSf;fpilNa FUj;jZ rpfpr;ir gw;wpa kdg;ghd;ikia 
mwpjy;. 
mwpTiu: 
 fPNo cs;s mwpf;if FUj;jZ rpfpr;ir gw;wpa kdg;ghd;ikia tpsf;FtJ 
MFk; Njh;thsh; fh;gfhy jha;khh;fs; mspf;Fk; gjpiy rhpahd fl;lj;jpy; [] 
FwpapLthh;. 
t. 
vz; mwpf;if c.x x.nfh ep., x.nfh.tp 
c.x. 
nfh.tp 
1. 
FUj;jZ rpfpr;ir ve;j tpj Mgj;Jk; 
,y;yhjJ Vndd;why; ekJ clypy; 
,Ue;J ngwg;gl;lJ. 
     
2. 
njhg;Gs; nfhb uj;jk; Nrfhpf;Fk; 
NghJ> Foe;ij ve;j topapYk; 
ghjpf;fg;gltpy;iy. 
     
3. 
FUj;jZf;fs; gytpj Neha;fis 
FzgLj;j cjTfpwJ.      
4. 
FUj;jZf;fis ePz;l fhyk; tiu 
Nrkpf;f KbAk;.      
5. 
FUj;jZf;fs; eQ;Rf;nfhbapypUe;J 
ngwg;gl;lit.      
6. 
taJ te;Njhh;fspd; FUj;jZf;fs; 
kl;Lk; vYk;G k[;i[apy; 
fhzg;gLfpwJ. 
     
7. 
kUj;Jt eilKiw MNyhrid gb 
jha;khh;fs; FUj;jZf;fis NtNwDk; 
Nehf;fj;jpw;fhf Nrkpf;fpd;wd. 
     
8. 
fU FUj;jZf;fs; gpsh];Nlhrp];bd; 
cs;nry;jpuspypUe;J ngwg;gLfpwJ.      
9. 
FUj;jZf;fspd; %yk; ePhpopT> ,ja 
Neha; kw;Wk; euk;G jsh;r;rp Neha;fis 
Fzg;gLj;j KbAk;. 
     
10. 
FUj;jZ Muha;r;rp Kiw %yk; 
Fzkhjypy; fbdk; vd;w nfhs;if 
jhkjkhf te;jhy; mJ nfh^ukhdJ. 
     
11. 
fUit xg;gpl;L ghh;f;Fk; nghOJ 
njhg;Gs; nfhb FUj;jZf;fis 
gad;gLj;JtJ vspJ. 
     
12. 
njhg;Gs;nfho FUj;jZf;fs; xU 
mjpfgbahd Mjhukhf cs;sJ.      
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13. 
njhg;Gs;nfhb FUj;jZf;fs; Foe;ij 
gpwe;jTld; vLf;fgLfpwJ.      
14. 
nryT kypT vd;why; ehd; vd; 
Foe;ijapd; njhg;Gs;nfhb ,uj;jj;ij 
Nrkpf;f KbAk;. 
     
15. 
cq;fSila Foe;ijapd; njhg;Gs; 
nfhb ,uj;jk; mth;fspd; cld; 
gpwe;jth;fSf;Fk; nghUe;Jkh? 
     
16. 
fU FUj;jZf;fspd; Muha;r;rp 
rl;ltpNuhjk; kw;Wk; Njitaw;wJ.      
17. 
FUj;jZf;fis kpf Fiwe;j 
ntg;gepiyapy; ghJfhf;f KbAk;.      
18. 
njhg;Gs; nfhb FUj;jZf;fis 
vLf;Fk; nghOJ Foe;ijfs; 
ghjpf;fg;gLfpd;wd. 
     
19. 
FUj;jZ rpfpr;irapd; %yk; jyrPkpah> 
,uj;jGw;WNeha; kw;Wk; epzePh; 
Gw;WNeha; FzgLj;j KbAk;. 
     
20. 
FUj;jZ khw;W rpfpr;ir Kiwia 
nghpa mstpy; 
eilKiwgLj;jgLfpd;wd. 
     
 
c.x: cWjpahf xg;Gnfhs;fpNwd;. 
 
x.nfh: xg;Gf; nfhs;fpNwd;. 
 
ep.,: epiyapy;yhik. 
 
x.nfh.tp: xg;G nfhs;stpy;iy. 
 
c.x.nfh.tp: cWjpahf 
xg;Gf;nfhs;stpy;iy. 
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குருத்த  ெி ிச்னெ பற்றிய 
பாடத்திட்டம்
   
     
              
NôRôWQ ùNp AûUlûT Tt± YûWVû\
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               :
             
ÏÚjRÔ YûWVû\ :
 
ÏÚjRÔ £¡fûN Øû\ Tt±V YWXôß :
• 1974-p ØRu ØR-p U²R ùRôl×sùLô¥ CWjR
ÏÚjRÔdLs LiÓ©¥dLThPÕ.
• 1983-p PôdPo aôp ©WôdvªVo Utßm ùLôúX´Vv ØRu
ØR-p ùRôl×sùLô¥ WjR Ye¡ BRôW ùLôsûLûV
EÚYôd¡]o.
• 1990-p CWjR ×tßúSôn (ùYsû[ AàdLs) £¡fûNûV
EX¡u ØRu ØR-p ùRôl×sùLô¥ CWjR Uôtß Øû\ûV
ª]úNôhPô TpLûXdLZLj§p PôdPo._ôuYôd]o 
ùNVpTÓj§]ôo.
• 2008-p EXL A[®p 12,000 úToLÞdÏ ÏÚjRÔdLs
Uôt\lThÓs[Õ. CR]ôp CWjR NôokR úSônLs
ÏQlTÓjRlThÓ YÚ¡u\].
     
ÏÚjRÔdL°u YûLLs :
•LÚ ÏÚjRÔdLs
•§Ñ Ï±l©hP
ÏÚjRÔdLs
•CûPÖûZj§Ñ
ÏÚjRÔdLs
•TX§\uLû[ 
çi¥V
ÏÚjRÔdLs.
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ÏÚjRÔ®u Ti×Ls :
ÏÚjRÔdLs EP-p Ut\
YûLVô] ùNpLL°-ÚkÕ
úYßTÓ¡u\]. Aû]jÕ
ÏÚjRÔdLÞm ùTôÕYô] 
êuß Ti×Lû[ ùLôiÓ
Es[Õ.
¿iP LôXj§tÏ ReLû[ 
©[Ü Utßm ×Õl©dÏm
§\u ùLôiPûY.
GkR®RUô] £\l×
Ti×Lû[Ùm ùLôiPÕ
ApX.
A§LlT¥Vô] £\l×
ùNpL°u YûLLû[ 
ùLôÓdL Ø¥Ùm.
ùRôl×s ùLô¥ CWjRj§u êXm £¡fûN 
úSônLû[ LQd¡ÓRp
ÏÚjRÔLû[ úNL¬dÏm SûPØû\Lû[ 
®[dÏRp
UÚjÕYUû]«p 1 - 6 
UôR CûPùY°«p 
SgÑdùLô¥ 
ÏÚjRÔdLs úNL¬l×
ùRôPoTôL úNûY
ûUUVeL°p ùR¬®dL
úYiÓm.
ùRôl×sùLô¥ CWjRYe¡ 
úNL¬l× ûUVeLs
Ck§Vô®p TpúYß
CPeL[ô] ùNuû], 
ØmûT, ×ÕùPp-, ×ú], 
ùLôpLjRô, ûaRWôTôj, 
ùTeLðo, ALURôTôj
Utßm TX SLWeL°Ûm
Es[].
        
ÏÚjRÔLû[ úNL¬dÏm SûPØû\Lû[ 
®[dÏRp
        
     
21           
ஜெய்முனறக் 
 ட்டணம் 10,000 10,000 10,000
பதிவுக்
 ட்டணம் 3,500/ மாதம் 25,000 (ஒகர 
தவனண)
40,000 (ஒகர 
தவனண)
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•கு ந்னத பிறந்தவுடன் 
ஜதாப்புள்ஜ ா  
ஜவட்டப்படு ிறது 
• திலிருந்து தான் 
குருத்த  
கெ ரிப்பதற்கு  ரத்தம் 
ஜபறப்படு ிறது 
•  தைால் தாய் 
மற்றும் கெய்க்கு  ந்த 
விதமாை 
பாதிப்பும் வலியும் 
 ல்னல 
        
JÚ £\l× CWjR
ûT«p
ùRôl×sùLô¥ 
CWjRm
úNL¬dLlThÓ
Ï±«PlTÓ¡\Õ.
        
¡ûWúVô TôÕLôl×
ùNVpØû\«p 
ÏÚjRÔdLs
ùRôl×sùLô¥ 
CWjRj§p CÚkÕ
GÓdLlThÓ éw´Vm
ùYlT¨ûX«p
(196
0 c) Tj§WUôL
TôÕLôdLlTÓ¡\Õ.
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ABSTARCT 
 
Cord blood stem cell research has been extensively explored worldwide to 
enhance human health in medical setting. Stem cells have tremendous promise to 
helping us to understand and treat a range of various diseases, injuries and other health-
related conditions. Their potential is evident in the use of cord blood stem cells to treat 
diseases of the blood, A cord blood stem cell therapy has saved the lives of thousands of 
children with leukemia; and can be seen in the use of stem cells for tissue grafts to treat 
diseases or injury to the bone, skin and surface of the eye. Important clinical trials 
involving stem cells are underway for many other conditions and researchers continue to 
explore new avenues using stem cells in medicine. 
Genetic disorder rate in India 64.4 % (per 1000 live births),Rao and Ghose (2005) 
report that 1 out of 20 children admitted to hospital has a genetic disorder that ultimately 
account for about 1 out of 10 childhood deaths. In India ultimately urban area are affected 
with congenital malformation and genetic disorder are the third most common cause of 
mortality in newborns. There are an estimated 60-80 million people in the world who 
carry the beta thalassemia trait. People who carry thalassemia in India alone number 
approximately 30 million. 
The main objective of the study is to assess effectiveness of structured teaching 
programme on knowledge and attitude regarding stem cell therapy among antenatal 
mothers in selected private hospitals at Namakkal district. One group pretest and posttest 
design was used for this study. The independent variable in this study is structure 
teaching program on cord blood stem cell therapy. The dependent variables in this study 
are knowledge and attitude. The study was conducted at jayaa and suguna hospital 
Tiruchengode which is a 100 bedded hospitals. 
Sample includes antenatal mothers with stem cell therapy at jayaa and suguna 
hospitals, who fulfils the inclusion criteria were selected by non probability convenient 
sampling technique. Structured teaching on knowledge and attitude regarding stem cell 
therapy among antenatal mothers. 
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 The comparison of pretest, the mean score of knowledge was 11.50 with S.D 
2.70 whereas in the post test the mean score of knowledge was 33.06 with S.D 3.93. The 
calculated paired‗t‘ value of t = 57.742 was found to statistically significant at p<0.001 
level. This clearly shows that the structured teaching programme imparted to antenatal 
mothers had significant improvement in the post test level of knowledge regarding cord 
blood stem cell therapy. 
There was a significant improvement of knowledge and attitude regarding stem 
cell therapy among antenatal mothers at Jayaa and Suguna hospitals after structured 
teaching as an intervention. Thus structured teaching on stem cell therapy was an 
effective intervention in the enhancement of knowledge and attitude among antenatal 
mothers. 
The present study conducted by the investigator, mainly focused on the structured 
teaching programme to improve the knowledge and attitude on stem cell therapy and was 
found effective and also the researcher insisted the antenatal mothers should improve the 
knowledge of stem cell therapy. 
 
 
 
 
